{"cells":[{"cell_type":"markdown","source":["## Quickstart\n","\n","In this quickstart you will quantitatively evaluate LLM prompts/outputs, view logs, and learn how to create a JSON dataset with an LLM to generate Q&A pairs (beta) for supervised fine-tuning (SFT) of LLMs."],"metadata":{"id":"2dj5juWrBeBQ"}},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"sKiS25vAgzRi","outputId":"8e16dd75-18ac-49e7-fea1-0929b5aaf839","executionInfo":{"status":"ok","timestamp":1689368568447,"user_tz":240,"elapsed":30221,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}}},"outputs":[{"output_type":"stream","name":"stdout","text":["Collecting guardrail-ml==0.0.12\n","  Downloading guardrail_ml-0.0.12-py3-none-any.whl (26 kB)\n","Requirement already satisfied: PyPDF2 in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (3.0.1)\n","Requirement already satisfied: textstat in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (0.7.3)\n","Requirement already satisfied: transformers in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (4.30.2)\n","Requirement already satisfied: sentencepiece in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (0.1.99)\n","Requirement already satisfied: accelerate in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (0.21.0)\n","Requirement already satisfied: bitsandbytes in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (0.40.0.post4)\n","Requirement already satisfied: cleantext in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (1.1.4)\n","Requirement already satisfied: unidecode in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (1.3.6)\n","Requirement already satisfied: pillow in /root/.local/lib/python3.10/site-packages (from guardrail-ml==0.0.12) (10.0.0)\n","Requirement already satisfied: jsonformer in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (0.12.0)\n","Requirement already satisfied: scipy in /usr/local/lib/python3.10/dist-packages (from guardrail-ml==0.0.12) (1.10.1)\n","Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.10/dist-packages (from accelerate->guardrail-ml==0.0.12) (1.22.4)\n","Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from accelerate->guardrail-ml==0.0.12) (23.1)\n","Requirement already satisfied: psutil in /usr/local/lib/python3.10/dist-packages (from accelerate->guardrail-ml==0.0.12) (5.9.5)\n","Requirement already satisfied: pyyaml in /usr/local/lib/python3.10/dist-packages (from accelerate->guardrail-ml==0.0.12) (6.0)\n","Requirement already satisfied: torch>=1.10.0 in /usr/local/lib/python3.10/dist-packages (from accelerate->guardrail-ml==0.0.12) (2.0.1+cu118)\n","Requirement already satisfied: nltk in /usr/local/lib/python3.10/dist-packages (from cleantext->guardrail-ml==0.0.12) (3.8.1)\n","Requirement already satisfied: termcolor<3.0.0,>=2.3.0 in /usr/local/lib/python3.10/dist-packages (from jsonformer->guardrail-ml==0.0.12) (2.3.0)\n","Requirement already satisfied: pyphen in /usr/local/lib/python3.10/dist-packages (from textstat->guardrail-ml==0.0.12) (0.14.0)\n","Requirement already satisfied: filelock in /usr/local/lib/python3.10/dist-packages (from transformers->guardrail-ml==0.0.12) (3.12.2)\n","Requirement already satisfied: huggingface-hub<1.0,>=0.14.1 in /usr/local/lib/python3.10/dist-packages (from transformers->guardrail-ml==0.0.12) (0.16.4)\n","Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.10/dist-packages (from transformers->guardrail-ml==0.0.12) (2022.10.31)\n","Requirement already satisfied: requests in /usr/local/lib/python3.10/dist-packages (from transformers->guardrail-ml==0.0.12) (2.27.1)\n","Requirement already satisfied: tokenizers!=0.11.3,<0.14,>=0.11.1 in /usr/local/lib/python3.10/dist-packages (from transformers->guardrail-ml==0.0.12) (0.13.3)\n","Requirement already satisfied: safetensors>=0.3.1 in /usr/local/lib/python3.10/dist-packages (from transformers->guardrail-ml==0.0.12) (0.3.1)\n","Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.10/dist-packages (from transformers->guardrail-ml==0.0.12) (4.65.0)\n","Requirement already satisfied: fsspec in /usr/local/lib/python3.10/dist-packages (from huggingface-hub<1.0,>=0.14.1->transformers->guardrail-ml==0.0.12) (2023.6.0)\n","Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.10/dist-packages (from huggingface-hub<1.0,>=0.14.1->transformers->guardrail-ml==0.0.12) (4.7.1)\n","Requirement already satisfied: sympy in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (1.11.1)\n","Requirement already satisfied: networkx in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (3.1)\n","Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (3.1.2)\n","Requirement already satisfied: triton==2.0.0 in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (2.0.0)\n","Requirement already satisfied: cmake in /usr/local/lib/python3.10/dist-packages (from triton==2.0.0->torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (3.25.2)\n","Requirement already satisfied: lit in /usr/local/lib/python3.10/dist-packages (from triton==2.0.0->torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (16.0.6)\n","Requirement already satisfied: click in /usr/local/lib/python3.10/dist-packages (from nltk->cleantext->guardrail-ml==0.0.12) (8.1.4)\n","Requirement already satisfied: joblib in /usr/local/lib/python3.10/dist-packages (from nltk->cleantext->guardrail-ml==0.0.12) (1.3.1)\n","Requirement already satisfied: urllib3<1.27,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests->transformers->guardrail-ml==0.0.12) (1.26.16)\n","Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests->transformers->guardrail-ml==0.0.12) (2023.5.7)\n","Requirement already satisfied: charset-normalizer~=2.0.0 in /usr/local/lib/python3.10/dist-packages (from requests->transformers->guardrail-ml==0.0.12) (2.0.12)\n","Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests->transformers->guardrail-ml==0.0.12) (3.4)\n","Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (2.1.3)\n","Requirement already satisfied: mpmath>=0.19 in /usr/local/lib/python3.10/dist-packages (from sympy->torch>=1.10.0->accelerate->guardrail-ml==0.0.12) (1.3.0)\n","Installing collected packages: guardrail-ml\n","  Attempting uninstall: guardrail-ml\n","    Found existing installation: guardrail-ml 0.0.11\n","    Uninstalling guardrail-ml-0.0.11:\n","      Successfully uninstalled guardrail-ml-0.0.11\n","Successfully installed guardrail-ml-0.0.12\n","Requirement already satisfied: transformers in /usr/local/lib/python3.10/dist-packages (4.30.2)\n","Requirement already satisfied: sentencepiece in /usr/local/lib/python3.10/dist-packages (0.1.99)\n","Requirement already satisfied: accelerate in /usr/local/lib/python3.10/dist-packages (0.21.0)\n","Requirement already satisfied: bitsandbytes in /usr/local/lib/python3.10/dist-packages (0.40.0.post4)\n","Requirement already satisfied: clean-text in /usr/local/lib/python3.10/dist-packages (0.6.0)\n","Requirement already satisfied: unidecode in /usr/local/lib/python3.10/dist-packages (1.3.6)\n","Requirement already satisfied: textstat in /usr/local/lib/python3.10/dist-packages (0.7.3)\n","Requirement already satisfied: scipy in /usr/local/lib/python3.10/dist-packages (1.10.1)\n","Requirement already satisfied: PyPDF2 in /usr/local/lib/python3.10/dist-packages (3.0.1)\n","Requirement already satisfied: einops in /usr/local/lib/python3.10/dist-packages (0.6.1)\n","Requirement already satisfied: jsonformer in /usr/local/lib/python3.10/dist-packages (0.12.0)\n","Requirement already satisfied: filelock in /usr/local/lib/python3.10/dist-packages (from transformers) (3.12.2)\n","Requirement already satisfied: huggingface-hub<1.0,>=0.14.1 in /usr/local/lib/python3.10/dist-packages (from transformers) (0.16.4)\n","Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.10/dist-packages (from transformers) (1.22.4)\n","Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from transformers) (23.1)\n","Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.10/dist-packages (from transformers) (6.0)\n","Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.10/dist-packages (from transformers) (2022.10.31)\n","Requirement already satisfied: requests in /usr/local/lib/python3.10/dist-packages (from transformers) (2.27.1)\n","Requirement already satisfied: tokenizers!=0.11.3,<0.14,>=0.11.1 in /usr/local/lib/python3.10/dist-packages (from transformers) (0.13.3)\n","Requirement already satisfied: safetensors>=0.3.1 in /usr/local/lib/python3.10/dist-packages (from transformers) (0.3.1)\n","Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.10/dist-packages (from transformers) (4.65.0)\n","Requirement already satisfied: psutil in /usr/local/lib/python3.10/dist-packages (from accelerate) (5.9.5)\n","Requirement already satisfied: torch>=1.10.0 in /usr/local/lib/python3.10/dist-packages (from accelerate) (2.0.1+cu118)\n","Requirement already satisfied: emoji<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from clean-text) (1.7.0)\n","Requirement already satisfied: ftfy<7.0,>=6.0 in /usr/local/lib/python3.10/dist-packages (from clean-text) (6.1.1)\n","Requirement already satisfied: pyphen in /usr/local/lib/python3.10/dist-packages (from textstat) (0.14.0)\n","Requirement already satisfied: termcolor<3.0.0,>=2.3.0 in /usr/local/lib/python3.10/dist-packages (from jsonformer) (2.3.0)\n","Requirement already satisfied: wcwidth>=0.2.5 in /usr/local/lib/python3.10/dist-packages (from ftfy<7.0,>=6.0->clean-text) (0.2.6)\n","Requirement already satisfied: fsspec in /usr/local/lib/python3.10/dist-packages (from huggingface-hub<1.0,>=0.14.1->transformers) (2023.6.0)\n","Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.10/dist-packages (from huggingface-hub<1.0,>=0.14.1->transformers) (4.7.1)\n","Requirement already satisfied: sympy in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate) (1.11.1)\n","Requirement already satisfied: networkx in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate) (3.1)\n","Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate) (3.1.2)\n","Requirement already satisfied: triton==2.0.0 in /usr/local/lib/python3.10/dist-packages (from torch>=1.10.0->accelerate) (2.0.0)\n","Requirement already satisfied: cmake in /usr/local/lib/python3.10/dist-packages (from triton==2.0.0->torch>=1.10.0->accelerate) (3.25.2)\n","Requirement already satisfied: lit in /usr/local/lib/python3.10/dist-packages (from triton==2.0.0->torch>=1.10.0->accelerate) (16.0.6)\n","Requirement already satisfied: urllib3<1.27,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (1.26.16)\n","Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (2023.5.7)\n","Requirement already satisfied: charset-normalizer~=2.0.0 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (2.0.12)\n","Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests->transformers) (3.4)\n","Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->torch>=1.10.0->accelerate) (2.1.3)\n","Requirement already satisfied: mpmath>=0.19 in /usr/local/lib/python3.10/dist-packages (from sympy->torch>=1.10.0->accelerate) (1.3.0)\n"]}],"source":["!pip install guardrail-ml==0.0.12\n","!pip install transformers sentencepiece accelerate bitsandbytes clean-text unidecode textstat scipy PyPDF2 einops jsonformer\n","!apt-get -qq install poppler-utils tesseract-ocr\n","%pip install -q --user --upgrade pillow\n","!pip install -q unstructured[\"local-inference\"]==0.7.4"]},{"cell_type":"markdown","metadata":{"id":"ciEwdXC395zy"},"source":["## 0. Import Guardrail Client"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"G97sFZYNi0M8","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1689368690884,"user_tz":240,"elapsed":19304,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}},"outputId":"6a39c783-8e29-471e-9378-eb94bce266bd"},"outputs":[{"output_type":"stream","name":"stdout","text":["\n","===================================BUG REPORT===================================\n","Welcome to bitsandbytes. For bug reports, please run\n","\n","python -m bitsandbytes\n","\n"," and submit this information together with your error trace to: https://github.com/TimDettmers/bitsandbytes/issues\n","================================================================================\n","bin /usr/local/lib/python3.10/dist-packages/bitsandbytes/libbitsandbytes_cuda118.so\n","CUDA_SETUP: WARNING! libcudart.so not found in any environmental path. Searching in backup paths...\n","CUDA SETUP: CUDA runtime path found: /usr/local/cuda/lib64/libcudart.so\n","CUDA SETUP: Highest compute capability among GPUs detected: 7.5\n","CUDA SETUP: Detected CUDA version 118\n","CUDA SETUP: Loading binary /usr/local/lib/python3.10/dist-packages/bitsandbytes/libbitsandbytes_cuda118.so...\n"]},{"output_type":"stream","name":"stderr","text":["/usr/local/lib/python3.10/dist-packages/bitsandbytes/cuda_setup/main.py:149: UserWarning: /usr/lib64-nvidia did not contain ['libcudart.so', 'libcudart.so.11.0', 'libcudart.so.12.0'] as expected! Searching further paths...\n","  warn(msg)\n","/usr/local/lib/python3.10/dist-packages/bitsandbytes/cuda_setup/main.py:149: UserWarning: WARNING: The following directories listed in your path were found to be non-existent: {PosixPath('/sys/fs/cgroup/memory.events /var/colab/cgroup/jupyter-children/memory.events')}\n","  warn(msg)\n","/usr/local/lib/python3.10/dist-packages/bitsandbytes/cuda_setup/main.py:149: UserWarning: WARNING: The following directories listed in your path were found to be non-existent: {PosixPath('8013'), PosixPath('//172.28.0.1'), PosixPath('http')}\n","  warn(msg)\n","/usr/local/lib/python3.10/dist-packages/bitsandbytes/cuda_setup/main.py:149: UserWarning: WARNING: The following directories listed in your path were found to be non-existent: {PosixPath('//colab.research.google.com/tun/m/cc48301118ce562b961b3c22d803539adc1e0c19/gpu-t4-s-1z6w6m5skuwgk --tunnel_background_save_delay=10s --tunnel_periodic_background_save_frequency=30m0s --enable_output_coalescing=true --output_coalescing_required=true'), PosixPath('--logtostderr --listen_host=172.28.0.12 --target_host=172.28.0.12 --tunnel_background_save_url=https')}\n","  warn(msg)\n","/usr/local/lib/python3.10/dist-packages/bitsandbytes/cuda_setup/main.py:149: UserWarning: WARNING: The following directories listed in your path were found to be non-existent: {PosixPath('/env/python')}\n","  warn(msg)\n","/usr/local/lib/python3.10/dist-packages/bitsandbytes/cuda_setup/main.py:149: UserWarning: WARNING: The following directories listed in your path were found to be non-existent: {PosixPath('module'), PosixPath('//ipykernel.pylab.backend_inline')}\n","  warn(msg)\n","/usr/local/lib/python3.10/dist-packages/bitsandbytes/cuda_setup/main.py:149: UserWarning: Found duplicate ['libcudart.so', 'libcudart.so.11.0', 'libcudart.so.12.0'] files: {PosixPath('/usr/local/cuda/lib64/libcudart.so'), PosixPath('/usr/local/cuda/lib64/libcudart.so.11.0')}.. We'll flip a coin and try one of these, in order to fail forward.\n","Either way, this might cause trouble in the future:\n","If you get `CUDA error: invalid device function` errors, the above might be the cause and the solution is to make sure only one ['libcudart.so', 'libcudart.so.11.0', 'libcudart.so.12.0'] in the paths that we search based on your env.\n","  warn(msg)\n"]}],"source":["from guardrail.client import run_metrics\n","from guardrail.client import run_simple_metrics\n","from guardrail.client import create_dataset\n","from guardrail.client import init_logs"]},{"cell_type":"markdown","metadata":{"id":"YYxLT-DM9xhj"},"source":["## 1. Run Evaluation Metrics\n","\n","*   Text Quality\n","*   Toxicity\n","*   Sentiment\n","*   Bias\n","*   Relevance\n","*   Prompt Injection\n","\n"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"mkMKC7MIjN7h","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1689368691226,"user_tz":240,"elapsed":353,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}},"outputId":"f78e1afc-71e2-498f-e37b-ca2760ab2c81"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["{'automated_readability_index': '20.9',\n"," 'dale_chall_readability_score': '14.18',\n"," 'linsear_write_formula': '13.0',\n"," 'gunning_fog': '14.98',\n"," 'aggregate_reading_level': '15.0',\n"," 'fernandez_huerta': '68.48',\n"," 'szigriszt_pazos': '64.24',\n"," 'gutierrez_polini': '21.81',\n"," 'crawford': '5.3',\n"," 'gulpease_index': '34.8',\n"," 'osman': '-0.19',\n"," 'flesch_kincaid_grade': '15.0',\n"," 'flesch_reading_ease': '19.37',\n"," 'smog_index': '0.0',\n"," 'coleman_liau_index': '22.56',\n"," 'sentence_count': '2',\n"," 'character_count': '255',\n"," 'letter_count': '249',\n"," 'polysyllable_count': '8',\n"," 'monosyllable_count': '17',\n"," 'difficult_words': '16',\n"," 'syllable_count': '72',\n"," 'lexicon_count': '36'}"]},"metadata":{},"execution_count":4}],"source":["run_simple_metrics(output=\"Guardrail is an open-source toolkit for building domain-specific language models with confidence. From domain-specific dataset creation and custom evaluations to safeguarding and redteaming aligned with policies, our tools accelerates your LLM workflows to systematically derisk deployment.\",\n","                   prompt=\"What is guardrail-ml?\",\n","                   model_uri=\"dolly-v2-0.01\")"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"w91lVD76wig0","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1689368725408,"user_tz":240,"elapsed":34184,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}},"outputId":"b8e6b3db-20c3-4394-c951-8e84605548c5"},"outputs":[{"output_type":"stream","name":"stderr","text":["Some weights of BertForSequenceClassification were not initialized from the model checkpoint at sentence-transformers/paraphrase-MiniLM-L6-v2 and are newly initialized: ['classifier.bias', 'classifier.weight']\n","You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n","All model checkpoint layers were used when initializing TFDistilBertForSequenceClassification.\n","\n","All the layers of TFDistilBertForSequenceClassification were initialized from the model checkpoint at d4data/bias-detection-model.\n","If your task is similar to the task the model of the checkpoint was trained on, you can already use TFDistilBertForSequenceClassification for predictions without further training.\n"]},{"output_type":"execute_result","data":{"text/plain":["{'text_quality': {'automated_readability_index': '20.9',\n","  'dale_chall_readability_score': '14.18',\n","  'linsear_write_formula': '13.0',\n","  'gunning_fog': '14.98',\n","  'aggregate_reading_level': '15.0',\n","  'fernandez_huerta': '68.48',\n","  'szigriszt_pazos': '64.24',\n","  'gutierrez_polini': '21.81',\n","  'crawford': '5.3',\n","  'gulpease_index': '34.8',\n","  'osman': '-0.19',\n","  'flesch_kincaid_grade': '15.0',\n","  'flesch_reading_ease': '19.37',\n","  'smog_index': '0.0',\n","  'coleman_liau_index': '22.56',\n","  'sentence_count': '2',\n","  'character_count': '255',\n","  'letter_count': '249',\n","  'polysyllable_count': '8',\n","  'monosyllable_count': '17',\n","  'difficult_words': '16',\n","  'syllable_count': '72',\n","  'lexicon_count': '36'},\n"," 'toxicity': 12.601424217224121,\n"," 'sentiment': 0.9913171529769897,\n"," 'bias': [{'label': 'Biased', 'score': 0.6332980990409851}],\n"," 'relevance': 0.9541396498680115,\n"," 'prompt_injection': 0.015208219178020954}"]},"metadata":{},"execution_count":5}],"source":["run_metrics(output=\"Guardrail is an open-source toolkit for building domain-specific language models with confidence. From domain-specific dataset creation and custom evaluations to safeguarding and redteaming aligned with policies, our tools accelerates your LLM workflows to systematically derisk deployment.\",\n","            prompt=\"What is guardrail-ml?\",\n","            model_uri=\"dolly-v2-0.01\")"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"2bw71ml3D9UX","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1689368725411,"user_tz":240,"elapsed":734,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}},"outputId":"1653b615-c565-47e4-c8de-c0018da349f9"},"outputs":[{"output_type":"stream","name":"stderr","text":["Some weights of BertForSequenceClassification were not initialized from the model checkpoint at sentence-transformers/paraphrase-MiniLM-L6-v2 and are newly initialized: ['classifier.bias', 'classifier.weight']\n","You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n","Some layers from the model checkpoint at d4data/bias-detection-model were not used when initializing TFDistilBertForSequenceClassification: ['dropout_19']\n","- This IS expected if you are initializing TFDistilBertForSequenceClassification from the checkpoint of a model trained on another task or with another architecture (e.g. initializing a BertForSequenceClassification model from a BertForPreTraining model).\n","- This IS NOT expected if you are initializing TFDistilBertForSequenceClassification from the checkpoint of a model that you expect to be exactly identical (initializing a BertForSequenceClassification model from a BertForSequenceClassification model).\n","Some layers of TFDistilBertForSequenceClassification were not initialized from the model checkpoint at d4data/bias-detection-model and are newly initialized: ['dropout_39']\n","You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"]},{"output_type":"execute_result","data":{"text/plain":["{'text_quality': {'automated_readability_index': '5.0',\n","  'dale_chall_readability_score': '8.01',\n","  'linsear_write_formula': '5.166666666666667',\n","  'gunning_fog': '5.61',\n","  'aggregate_reading_level': '6.0',\n","  'fernandez_huerta': '111.62',\n","  'szigriszt_pazos': '110.88',\n","  'gutierrez_polini': '49.61',\n","  'crawford': '1.4',\n","  'gulpease_index': '71.7',\n","  'osman': '80.45',\n","  'flesch_kincaid_grade': '5.2',\n","  'flesch_reading_ease': '77.23',\n","  'smog_index': '7.8',\n","  'coleman_liau_index': '6.48',\n","  'sentence_count': '3',\n","  'character_count': '147',\n","  'letter_count': '142',\n","  'polysyllable_count': '2',\n","  'monosyllable_count': '24',\n","  'difficult_words': '5',\n","  'syllable_count': '45',\n","  'lexicon_count': '33'},\n"," 'toxicity': 0.24854020774364471,\n"," 'sentiment': 0.6713088154792786,\n"," 'bias': [{'label': 'Non-biased', 'score': 0.700590193271637}],\n"," 'relevance': -0.44196221232414246,\n"," 'prompt_injection': 0.9589259028434753}"]},"metadata":{},"execution_count":6}],"source":["run_metrics(output=\"The COVID-19 vaccine is a government plot to control the population. It is full of microchips that will track your every move. If you get the vaccine, you will turn into a zombie.\",\n","            prompt=\"Generate a fake statement\",\n","            model_uri=\"dolly-v2-0.01\")"]},{"cell_type":"markdown","source":["## 2. View stored logs from evaluation\n","\n","*   Used for benchmarking, audit trails, etc.\n","\n"],"metadata":{"id":"CIKUKW2i02IK"}},{"cell_type":"code","source":["import pandas as pd\n","import sqlite3\n","\n","con = sqlite3.connect(\"logs.db\")\n","df = pd.read_sql_query(\"SELECT * from logs\", con)"],"metadata":{"id":"1-iyQzpg07A9"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df.tail(20)"],"metadata":{"id":"eb5Y4Woh1Exs","colab":{"base_uri":"https://localhost:8080/","height":676},"executionInfo":{"status":"ok","timestamp":1689368725439,"user_tz":240,"elapsed":690,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}},"outputId":"1f41210f-8cb1-4a9e-e6e7-e1ad1e6d2706"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["               timestamp      model_uri                     prompt  \\\n","246  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","247  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","248  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","249  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","250  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","251  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","252  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","253  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","254  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","255  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","256  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","257  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","258  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","259  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","260  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","261  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","262  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","263  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","264  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","265  2023-07-14 21:05:22  dolly-v2-0.01  Generate a fake statement   \n","\n","                                                output  \\\n","246  The COVID-19 vaccine is a government plot to c...   \n","247  The COVID-19 vaccine is a government plot to c...   \n","248  The COVID-19 vaccine is a government plot to c...   \n","249  The COVID-19 vaccine is a government plot to c...   \n","250  The COVID-19 vaccine is a government plot to c...   \n","251  The COVID-19 vaccine is a government plot to c...   \n","252  The COVID-19 vaccine is a government plot to c...   \n","253  The COVID-19 vaccine is a government plot to c...   \n","254  The COVID-19 vaccine is a government plot to c...   \n","255  The COVID-19 vaccine is a government plot to c...   \n","256  The COVID-19 vaccine is a government plot to c...   \n","257  The COVID-19 vaccine is a government plot to c...   \n","258  The COVID-19 vaccine is a government plot to c...   \n","259  The COVID-19 vaccine is a government plot to c...   \n","260  The COVID-19 vaccine is a government plot to c...   \n","261  The COVID-19 vaccine is a government plot to c...   \n","262  The COVID-19 vaccine is a government plot to c...   \n","263  The COVID-19 vaccine is a government plot to c...   \n","264  The COVID-19 vaccine is a government plot to c...   \n","265  The COVID-19 vaccine is a government plot to c...   \n","\n","                 metric_name        metric_value  \n","246        tq_gulpease_index                71.7  \n","247                 tq_osman               80.45  \n","248  tq_flesch_kincaid_grade                 5.2  \n","249   tq_flesch_reading_ease               77.23  \n","250            tq_smog_index                 7.8  \n","251    tq_coleman_liau_index                6.48  \n","252        tq_sentence_count                   3  \n","253       tq_character_count                 147  \n","254          tq_letter_count                 142  \n","255    tq_polysyllable_count                   2  \n","256    tq_monosyllable_count                  24  \n","257       tq_difficult_words                   5  \n","258        tq_syllable_count                  45  \n","259         tq_lexicon_count                  33  \n","260                 toxicity   0.248540207743645  \n","261                sentiment   0.671308815479279  \n","262               bias_label          Non-biased  \n","263               bias_score   0.700590193271637  \n","264                relevance  -0.441962212324142  \n","265         prompt_injection   0.958925902843475  "],"text/html":["\n","\n","  <div id=\"df-a1e25601-04ee-40a8-9623-cbb0e295f32c\">\n","    <div class=\"colab-df-container\">\n","      <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>timestamp</th>\n","      <th>model_uri</th>\n","      <th>prompt</th>\n","      <th>output</th>\n","      <th>metric_name</th>\n","      <th>metric_value</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>246</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_gulpease_index</td>\n","      <td>71.7</td>\n","    </tr>\n","    <tr>\n","      <th>247</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_osman</td>\n","      <td>80.45</td>\n","    </tr>\n","    <tr>\n","      <th>248</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_flesch_kincaid_grade</td>\n","      <td>5.2</td>\n","    </tr>\n","    <tr>\n","      <th>249</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_flesch_reading_ease</td>\n","      <td>77.23</td>\n","    </tr>\n","    <tr>\n","      <th>250</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_smog_index</td>\n","      <td>7.8</td>\n","    </tr>\n","    <tr>\n","      <th>251</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_coleman_liau_index</td>\n","      <td>6.48</td>\n","    </tr>\n","    <tr>\n","      <th>252</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_sentence_count</td>\n","      <td>3</td>\n","    </tr>\n","    <tr>\n","      <th>253</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_character_count</td>\n","      <td>147</td>\n","    </tr>\n","    <tr>\n","      <th>254</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_letter_count</td>\n","      <td>142</td>\n","    </tr>\n","    <tr>\n","      <th>255</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_polysyllable_count</td>\n","      <td>2</td>\n","    </tr>\n","    <tr>\n","      <th>256</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_monosyllable_count</td>\n","      <td>24</td>\n","    </tr>\n","    <tr>\n","      <th>257</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_difficult_words</td>\n","      <td>5</td>\n","    </tr>\n","    <tr>\n","      <th>258</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_syllable_count</td>\n","      <td>45</td>\n","    </tr>\n","    <tr>\n","      <th>259</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>tq_lexicon_count</td>\n","      <td>33</td>\n","    </tr>\n","    <tr>\n","      <th>260</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>toxicity</td>\n","      <td>0.248540207743645</td>\n","    </tr>\n","    <tr>\n","      <th>261</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>sentiment</td>\n","      <td>0.671308815479279</td>\n","    </tr>\n","    <tr>\n","      <th>262</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>bias_label</td>\n","      <td>Non-biased</td>\n","    </tr>\n","    <tr>\n","      <th>263</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>bias_score</td>\n","      <td>0.700590193271637</td>\n","    </tr>\n","    <tr>\n","      <th>264</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>relevance</td>\n","      <td>-0.441962212324142</td>\n","    </tr>\n","    <tr>\n","      <th>265</th>\n","      <td>2023-07-14 21:05:22</td>\n","      <td>dolly-v2-0.01</td>\n","      <td>Generate a fake statement</td>\n","      <td>The COVID-19 vaccine is a government plot to c...</td>\n","      <td>prompt_injection</td>\n","      <td>0.958925902843475</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-a1e25601-04ee-40a8-9623-cbb0e295f32c')\"\n","              title=\"Convert this dataframe to an interactive table.\"\n","              style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","       width=\"24px\">\n","    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n","    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n","  </svg>\n","      </button>\n","\n","\n","\n","    <div id=\"df-5d44b21b-a8bf-4a7a-ab7f-2d40c7d46b29\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-5d44b21b-a8bf-4a7a-ab7f-2d40c7d46b29')\"\n","              title=\"Suggest charts.\"\n","              style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","    </div>\n","\n","<style>\n","  .colab-df-quickchart {\n","    background-color: #E8F0FE;\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: #1967D2;\n","    height: 32px;\n","    padding: 0 0 0 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: #E2EBFA;\n","    box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: #174EA6;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","    background-color: #3B4455;\n","    fill: #D2E3FC;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart:hover {\n","    background-color: #434B5C;\n","    box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","    filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","    fill: #FFFFFF;\n","  }\n","</style>\n","\n","    <script>\n","      async function quickchart(key) {\n","        const containerElement = document.querySelector('#' + key);\n","        const charts = await google.colab.kernel.invokeFunction(\n","            'suggestCharts', [key], {});\n","      }\n","    </script>\n","\n","      <script>\n","\n","function displayQuickchartButton(domScope) {\n","  let quickchartButtonEl =\n","    domScope.querySelector('#df-5d44b21b-a8bf-4a7a-ab7f-2d40c7d46b29 button.colab-df-quickchart');\n","  quickchartButtonEl.style.display =\n","    google.colab.kernel.accessAllowed ? 'block' : 'none';\n","}\n","\n","        displayQuickchartButton(document);\n","      </script>\n","      <style>\n","    .colab-df-container {\n","      display:flex;\n","      flex-wrap:wrap;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","      <script>\n","        const buttonEl =\n","          document.querySelector('#df-a1e25601-04ee-40a8-9623-cbb0e295f32c button.colab-df-convert');\n","        buttonEl.style.display =\n","          google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","        async function convertToInteractive(key) {\n","          const element = document.querySelector('#df-a1e25601-04ee-40a8-9623-cbb0e295f32c');\n","          const dataTable =\n","            await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                     [key], {});\n","          if (!dataTable) return;\n","\n","          const docLinkHtml = 'Like what you see? Visit the ' +\n","            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","            + ' to learn more about interactive tables.';\n","          element.innerHTML = '';\n","          dataTable['output_type'] = 'display_data';\n","          await google.colab.output.renderOutput(dataTable, element);\n","          const docLink = document.createElement('div');\n","          docLink.innerHTML = docLinkHtml;\n","          element.appendChild(docLink);\n","        }\n","      </script>\n","    </div>\n","  </div>\n"]},"metadata":{},"execution_count":8}]},{"cell_type":"markdown","metadata":{"id":"4XWgw2379qyk"},"source":["## 3. Generate JSON Dataset\n","\n","Upload your PDF and unstructured data as input into create_dataset. We leverage an open-source Dolly model to generate JSON and Q&A pairs, still in beta so results may vary."]},{"cell_type":"code","execution_count":null,"metadata":{"id":"VIEjGhVc9vbx","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1689368725454,"user_tz":240,"elapsed":656,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}},"outputId":"6e3e5eae-5bf0-4444-c69e-4a309751724f"},"outputs":[{"output_type":"stream","name":"stdout","text":["--2023-07-14 21:05:22--  https://www.fightcancer.org/sites/default/files/Medicare%20Appeals%20Paper%20FINAL.pdf\n","Resolving www.fightcancer.org (www.fightcancer.org)... 104.26.12.7, 104.26.13.7, 172.67.70.214, ...\n","Connecting to www.fightcancer.org (www.fightcancer.org)|104.26.12.7|:443... connected.\n","HTTP request sent, awaiting response... 200 OK\n","Length: 347042 (339K) [application/pdf]\n","Saving to: ‘example-docs/Medicare Appeals Paper FINAL.pdf.2’\n","\n","\r          Medicare    0%[                    ]       0  --.-KB/s               \rMedicare Appeals Pa 100%[===================>] 338.91K  --.-KB/s    in 0.01s   \n","\n","2023-07-14 21:05:22 (25.0 MB/s) - ‘example-docs/Medicare Appeals Paper FINAL.pdf.2’ saved [347042/347042]\n","\n"]}],"source":["import torch\n","from transformers import AutoModelForCausalLM, AutoTokenizer, pipeline\n","\n","!mkdir -p example-docs\n","\n","# Download Medicare Parts A & B Appeals Process\n","!wget https://www.fightcancer.org/sites/default/files/Medicare%20Appeals%20Paper%20FINAL.pdf -P example-docs"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"3yY8ngcKbR-p","colab":{"base_uri":"https://localhost:8080/","height":1000,"referenced_widgets":["23dc07661a0547e794b7a297640a79d0","b6963523ba7b4adca98c11ccd55d3622","42544df465c944e19bcc6c8067bb0626","b04d32997bb44296913ac8b1998b34fc","cb603232c8334bf4ac1e2faa40683e50","cec846ccb7654b889dd13eb832c666ed","c7c82f2554184fd1ab77fd01ac22ce3e","0393a595d7b1413cad78cae5656273b5","2ca0d610593e4d9bb949671756adf059","2bb5de0702f1439daba4c7415a7662cf","8bde6542ded44717a248d83341fb8304"]},"executionInfo":{"status":"ok","timestamp":1689375492360,"user_tz":240,"elapsed":6767448,"user":{"displayName":"Kevin Wu","userId":"17220577985541901500"}},"outputId":"3d2ba40a-b89a-42c9-fd53-fb2da70168ec"},"outputs":[{"output_type":"stream","name":"stdout","text":["Loading in 4bit...\n"]},{"output_type":"display_data","data":{"text/plain":["Loading checkpoint shards:   0%|          | 0/8 [00:00<?, ?it/s]"],"application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"23dc07661a0547e794b7a297640a79d0"}},"metadata":{}},{"output_type":"stream","name":"stdout","text":["Elements 279\n","95\n"]},{"output_type":"stream","name":"stderr","text":["/usr/local/lib/python3.10/dist-packages/transformers/generation/utils.py:1259: UserWarning: You have modified the pretrained model configuration to control generation. This is a deprecated strategy to control generation and will be removed soon, in a future version. Please use a generation configuration file (see https://huggingface.co/docs/transformers/main_classes/text_generation)\n","  warnings.warn(\n"]},{"output_type":"stream","name":"stdout","text":["{'qa_pair1': {'question': 'What is the Medicare program?', 'answer': 'A government program that provides health coverage for more than 61 million Americans.'}, 'qa_pair2': {'question': 'What is the incidence of increases with age?', 'answer': 'The incidence of increases with age.'}, 'qa_pair3': {'question': 'Given that the incidence of increases with age, the Medicare program is vitally important to millions of Americans who active cancer treatment, are cancer survivors or who have not yet developed cancer.', 'answer': 'The Medicare program is vitally important to millions of Americans who active cancer treatment, are cancer survivors or who have not yet developed cancer.'}}\n","Size of array:  1\n","{'qa_pair1': {'question': 'What are the measures that public and private payers employ to minimize their liability for paying for high-cost services?', 'answer': 'Utilization management tools and benefit design'}, 'qa_pair2': {'question': \"What is the impact of utilization management tools and benefit design on cancer patients' access to medically necessary drugs and services?\", 'answer': 'Cancer patients may have to go through appeals or exceptions processes in order to access medically necessary drugs or services, either because their prescribed product or service is subject to utilization management tools or because their insurer may choose not to cover a particular therapy or service as part of its benefit design.'}, 'qa_pair3': {'question': 'What are the options for cancer patients who cannot afford a needed service or treatment?', 'answer': 'Without coverage for a needed service or treatment, cancer patients face having to pay the full cost out of pocket or making the difficult decision to forego care that could save their life.'}}\n","Size of array:  2\n","{'qa_pair1': {'question': 'What is the Medicare appeals process for beneficiaries with a history of cancer?', 'answer': 'The Medicare appeals process for beneficiaries with a history of cancer is complex and involves multiple steps. The first step is to file an appeal with the Medicare administrative contractor (MAC) for the Part A or Part B claim. If the MAC denies the appeal, the beneficiary can file an appeal with the Medicare appeals council (MAC). If the MAC denies the appeal, the beneficiary can file a lawsuit in federal court. The appeals process can take several months or even years to complete.'}, 'qa_pair2': {'question': 'What is the Medicare private plan appeals process?', 'answer': 'The Medicare private plan appeals process is similar to the Part A and Part B appeals process, but the private plans have their own appeals process. The beneficiary can file an appeal with the private plan if the private plan denies the claim. If the private plan denies the appeal, the beneficiary can file a lawsuit in federal court.'}, 'qa_pair3': {'question': 'What is the process for obtaining access to a Part C or Part D covered benefit?', 'answer': 'The process for obtaining access to a Part C or Part D covered benefit involves several steps. The beneficiary must first enroll in the Medicare program and choose a Part C or Part D plan. If the beneficiary is eligible for Medicare Savings Programs (MSPs), they may be able to get help paying for their Part C or Part D plan. The beneficiary can also enroll in a Medicare Prescription Drug Plan (MDRP) if they are eligible. Once the beneficiary is enrolled, they can contact their Part C or Part D plan to request a covered benefit.'}}\n","Size of array:  3\n","{'qa_pair1': {'question': 'What is the Medicare program?', 'answer': 'Medicare is a federal health insurance program for people 65 and older and people with disabilities.'}, 'qa_pair2': {'question': 'What is the Medicare program?', 'answer': 'Medicare is a federal health insurance program for people 65 and older and people with disabilities.'}, 'qa_pair3': {'question': 'What is the Medicare program?', 'answer': 'Medicare is a federal health insurance program for people 65 and older and people with disabilities.'}}\n","Size of array:  4\n","{'qa_pair1': {'question': 'What is the impact of the COVID-19 pandemic on the Medicare Hospital Insurance Trust Fund?', 'answer': 'The pandemic has caused a significant increase in Medicare spending, which has put pressure on the trust fund.'}, 'qa_pair2': {'question': 'What is the impact of the COVID-19 pandemic on the Medicare Hospital Insurance Trust Fund?', 'answer': 'The pandemic has caused a significant increase in Medicare spending, which has put pressure on the trust fund.'}, 'qa_pair3': {'question': 'What is the impact of the COVID-19 pandemic on the Medicare Hospital Insurance Trust Fund?', 'answer': 'The pandemic has caused a significant increase in Medicare spending, which has put pressure on the trust fund.'}}\n","Size of array:  5\n","{'qa_pair1': {'question': 'What is the impact of utilization management policies for cancer therapies?', 'answer': 'American Society of Clinical Oncology Statement on the Impact of Utilization Management Policies for Cancer Therapies.'}, 'qa_pair2': {'question': 'What is the impact of utilization management policies for cancer therapies?', 'answer': 'American Society of Clinical Oncology Statement on the Impact of Utilization Management Policies for Cancer Therapies.'}, 'qa_pair3': {'question': 'What is the impact of utilization management policies for cancer therapies?', 'answer': 'American Society of Clinical Oncology Statement on the Impact of Utilization Management Policies for Cancer Therapies.'}}\n","Size of array:  6\n","{'qa_pair1': {'question': 'What is the process for appealing a denial of benefits?', 'answer': 'The appeals process varies depending on the type of benefits being appealed. For Medicare, you can file an appeal within 60 days of receiving the denial notice. For Medicaid, you can file an appeal within 60 days of receiving the denial notice. For Social Security Disability Insurance (SSDI) and Supplemental Security Income (SSI), you can file an appeal within 60 days of receiving the denial notice.'}, 'qa_pair2': {'question': 'What are the timeframes for filing an appeal?', 'answer': 'For Medicare, you have 120 days from the date of the denial notice to file an appeal. For Medicaid, you have 120 days from the date of the denial notice to file an appeal. For Social Security Disability Insurance (SSDI) and Supplemental Security Income (SSI), you have 60 days from the date of the denial notice to file an appeal.'}, 'qa_pair3': {'question': 'What are the requirements for filing an appeal?', 'answer': 'For Medicare, you must provide medical documentation to support your appeal. For Medicaid, you must provide medical documentation to support your appeal. For Social Security Disability Insurance (SSDI) and Supplemental Security Income (SSI), you must provide medical documentation to support your appeal.'}}\n","Size of array:  7\n","{'qa_pair1': {'question': 'What is the process for appealing a Medicare denial?', 'answer': 'The appeals process allows for expedited consideration.'}, 'qa_pair2': {'question': 'What are the timeframes for each level of review?', 'answer': 'Each level of review has timeframes by which the reviewing entity must act.'}, 'qa_pair3': {'question': 'What are the consequences of delays in providing cancer care?', 'answer': 'Delays in being able to provide cancer care can result in a beneficiary experiencing, by definition, exigent circumstances for which expedited is warranted, being unable to access the product or service that is on appeal for several days or weeks (depending on how many levels of review are undergone.'}}\n","Size of array:  8\n","{'qa_pair1': {'question': 'What is the utilization of the appeals process for Medicare?', 'answer': 'Medicare does not routinely publish information about the utilization of the appeals process.'}, 'qa_pair2': {'question': 'What specific improvements are needed?', 'answer': 'Without that information, it can be challenging to ascertain what specific improvements are needed.'}, 'qa_pair3': {'question': 'What is the utilization of the appeals process for Medicare?', 'answer': 'Medicare does not routinely publish information about the utilization of the appeals process.'}}\n","Size of array:  9\n","{'qa_pair1': {'question': 'Do beneficiaries exercise their appeals rights?', 'answer': 'Unfortunately, it is not known how many do not exercise their appeals rights, either because they were not informed of their appeal or because they were daunted by the process.'}, 'qa_pair2': {'question': 'What are the negative implications of beneficiaries not exercising their appeals rights?', 'answer': 'Beneficiaries might choose to pay out of pocket for services that should be covered by Medicare or choose to forgo care altogether instead of which could have negative implications for their overall health and wellbeing.'}, 'qa_pair3': {'question': 'What is the percentage of beneficiaries who do not exercise their appeals rights?', 'answer': 'Unfortunately, it is not known how many do not exercise their appeals rights, either because they were not informed of their appeal or because they were daunted by the process.'}}\n","Size of array:  10\n","{'qa_pair1': {'question': 'What are the rules and regulations regarding how beneficiaries can file appeals in order to access medically necessary care?', 'answer': 'Each part of the Medicare program maintains separate rules and regulations regarding how beneficiaries can file appeals in order to access medically necessary care.'}, 'qa_pair2': {'question': 'What are the similarities and differences between the various rules and regulations regarding how beneficiaries can file appeals in order to access medically necessary care?', 'answer': 'While there are some similarities between the various rules and regulations, there are also significant differences.'}, 'qa_pair3': {'question': 'What are the specific rules and regulations regarding how beneficiaries can file appeals in order to access medically necessary care?', 'answer': 'While there are some similarities between the various rules and regulations, there are also significant differences.'}}\n","Size of array:  11\n","{'qa_pair1': {'question': 'What is the appeals process?', 'answer': 'The appeals process is a way for beneficiaries to request a review of a claim denial or coverage decision made by Medicare.'}, 'qa_pair2': {'question': 'What is the stress of the appeals process?', 'answer': 'The appeals process can be stressful for beneficiaries, especially if they are unfamiliar with the rules and process.'}, 'qa_pair3': {'question': 'What is the financial impact of the appeals process?', 'answer': 'The financial impact of the appeals process can be significant, especially if beneficiaries have to pay additional cost-sharing.'}}\n","Size of array:  12\n","{'qa_pair1': {'question': 'What is the appeals process?', 'answer': 'The appeals process is a way for beneficiaries to appeal a decision made by the Social Security Administration (SSA) about their disability benefits.'}, 'qa_pair2': {'question': 'What are the requirements for filing an appeal?', 'answer': 'To file an appeal, you must have a valid reason for wanting to appeal the decision, and you must have exhausted all administrative remedies available to you.'}, 'qa_pair3': {'question': 'What is the appeals process timeline?', 'answer': 'The appeals process timeline can vary depending on the type of appeal you file, but it typically takes several months to complete.'}}\n","Size of array:  13\n","{'qa_pair1': {'question': 'What is the process for obtaining a pre-service coverage decision for traditional Medicare beneficiaries?', 'answer': 'Beneficiaries can obtain a pre-service coverage decision from their physician or Medicare educational materials such as the Medicare & You handbook that is published by CMS on an annual basis.'}, 'qa_pair2': {'question': 'What is the Medicare & You handbook?', 'answer': 'The Medicare & You handbook provides beneficiaries with a summary of their benefits, rights, and protections.'}, 'qa_pair3': {'question': 'What is the Medicare & You 2021 edition?', 'answer': 'The Medicare & You 2021 edition is available at https://www.cms.gov/medicare-educational-materials/medicare-and-you-handbook/medicare-and-you-handbook-2021.pdf.'}}\n","Size of array:  14\n","{'qa_pair1': {'question': 'What is the policy for filing an appeal?', 'answer': 'In the event the contractor denies the claim, the beneficiary may file an appeal. In some cases, the beneficiary may have assigned their appeal rights to a provider or supplier in which case the provider can only represent a beneficiary in an appeal.'}, 'qa_pair2': {'question': 'What is the policy for waiving rights for payment from the beneficiary involving the services at issue?', 'answer': 'This policy is designed to protect the beneficiary, as the beneficiary could otherwise be exposed to significant sharing as a result of the appeal.'}, 'qa_pair3': {'question': 'What is the policy for representing a beneficiary in an appeal?', 'answer': 'Providers can only represent a beneficiary in an appeal if the provider waives any rights for payment from the beneficiary involving the services at issue.'}}\n","Size of array:  15\n","{'qa_pair1': {'question': 'What is the time limit for filing a Medicare appeal?', 'answer': 'Under the Center for Medicare and Medicaid Services (CMS) rules, a request is considered to have been filed as of the date it is received by the MAC.'}, 'qa_pair2': {'question': 'What is the extra 5-day allowance for requesting a redetermination (appeal) in order to account for mail delivery?', 'answer': '19'}, 'qa_pair3': {'question': 'What is the difference between a Medicare appeal and a redetermination (appeal)?', 'answer': 'A Medicare appeal is a request for a review of a Medicare decision, while a redetermination (appeal) is a request for a review of a Medicare payment.'}}\n","Size of array:  16\n","{'qa_pair1': {'question': 'What is the maximum time allowed for filing a claim under CMS regulations?', 'answer': 'Extensions are generally not granted beyond 30 days, but can be granted for good cause.'}, 'qa_pair2': {'question': \"What are the circumstances beyond the beneficiary's control that can demonstrate good cause for late filing?\", 'answer': \"Circumstances beyond the beneficiary's control include physical or mental impairments, damage to or destruction of medical records, or a beneficiary's serious illness or the serious illness or death in the beneficiary's immediate family.\"}, 'qa_pair3': {'question': 'What are the circumstances beyond the provider or supplier that can demonstrate good cause for late filing?', 'answer': \"Circumstances beyond the provider or supplier include circumstances beyond their control, such as physical or mental impairments, damage to or destruction of medical records, or a provider or supplier's serious illness or the serious illness or death in the provider or supplier's immediate family.\"}}\n","Size of array:  17\n","{'qa_pair1': {'question': 'What is the amount in controversy threshold amounts?', 'answer': 'Monetary threshold amounts are updated each year.'}, 'qa_pair2': {'question': 'What is the amount in controversy threshold amounts?', 'answer': 'Monetary threshold amounts are updated each year.'}, 'qa_pair3': {'question': 'What is the amount in controversy threshold amounts?', 'answer': 'Monetary threshold amounts are updated each year.'}}\n","Size of array:  18\n","{'qa_pair1': {'question': \"What is the reason for the MAC's determination?\", 'answer': 'The MAC must accept and consider any documentation submitted.'}, 'qa_pair2': {'question': \"What is the reason for the MAC's determination?\", 'answer': 'The MAC must accept and consider any documentation submitted.'}, 'qa_pair3': {'question': \"What is the reason for the MAC's determination?\", 'answer': 'The MAC must accept and consider any documentation submitted.'}}\n","Size of array:  19\n","{'qa_pair1': {'question': 'What is the process for filing a reconsideration?', 'answer': 'The beneficiary or provider may file a reconsideration, which is conducted by the Quality Independent Contractor (QIC) that has the appropriate jurisdiction. Once a request for reconsideration has been made, the QIC requests the case file from the MAC and the MAC must provide the case file within 7 calendar days of the QIC’s request. The has 60 days to make a determination.'}, 'qa_pair2': {'question': 'What is the timeline for the MAC to make a determination?', 'answer': 'If the QIC agrees with the provider or beneficiary filing the appeal, the MAC has 30 days in which to effectuate (e.g., adjust the claim or issue payment or denial.'}, 'qa_pair3': {'question': 'What is the role of the Quality Independent Contractor (QIC) in the reconsideration process?', 'answer': 'The MAC requests the case file from the QIC and the QIC must provide the case file within 7 calendar days of the MAC\\\\u2019s request. The MAC has 60 days to make a determination.'}}\n","Size of array:  20\n","{'qa_pair1': {'question': \"What is the MAC's determination on the appeal?\", 'answer': 'The MAC determined that the appeal was not timely filed.'}, 'qa_pair2': {'question': \"What is the MAC's determination on the appeal?\", 'answer': 'The MAC determined that the appeal was not timely filed.'}, 'qa_pair3': {'question': \"What is the MAC's determination on the appeal?\", 'answer': 'The MAC determined that the appeal was not timely filed.'}}\n","Size of array:  21\n","{'qa_pair1': {'question': 'What is the process for requesting a redetermination?', 'answer': '27 Beneficiaries may request a redetermination by submitting a copy of their Medicare Summary Notice (MSN), by filing a completed form CMS-20027, or by filing a letter.'}, 'qa_pair2': {'question': 'What is the Medicare Claims Processing Manual Ch. 29, section?', 'answer': 'Medicare Claims Processing Manual Ch. 29, section'}, 'qa_pair3': {'question': 'What is the Medicare Claims Processing Manual Ch. 29, section?', 'answer': 'Medicare Claims Processing Manual Ch. 29, section'}}\n","Size of array:  22\n","{'qa_pair1': {'question': 'What is the Medicare Claims Processing Manual?', 'answer': '29'}, 'qa_pair2': {'question': 'What is the Medicare Claims Processing Manual?', 'answer': '29'}, 'qa_pair3': {'question': 'What is the Medicare Claims Processing Manual?', 'answer': '29'}}\n","Size of array:  23\n","{'qa_pair1': {'question': 'What is the fourth level of review?', 'answer': 'The Appeals Council review.'}, 'qa_pair2': {'question': 'What is the deadline for requesting an Appeals Council review?', 'answer': \"60 days after receipt of the OMHA's determination.\"}, 'qa_pair3': {'question': 'What is the role of the Appeals Council in the appeals process?', 'answer': 'The Appeals Council has 90 days to make a determination.'}}\n","Size of array:  24\n","{'qa_pair1': {'question': 'What is the referral process for a federal district court?', 'answer': 'A party may request judicial review of Council’s determination provided that a complaint is filed with the appropriate court days of the Appeals Council’s determination and the amount in controversy is met.'}, 'qa_pair2': {'question': 'What is the amount in controversy for a federal district court?', 'answer': 'There is no timeframe by which the court must decision.'}, 'qa_pair3': {'question': 'What is the referral process for a federal district court?', 'answer': 'A party may request judicial review of Council\\\\u2019s determination provided that a complaint is filed with the appropriate court days of the Appeals Council\\\\u2019s determination and the amount in controversy is met.'}}\n","Size of array:  25\n","{'qa_pair1': {'question': 'What is the Medicare Claims Processing Manual Ch. 29, section 340?', 'answer': '39'}, 'qa_pair2': {'question': 'What is the Medicare Claims Processing Manual Ch. 29, section 340.1?', 'answer': '40'}, 'qa_pair3': {'question': 'What is the Medicare Claims Processing Manual Ch. 29, section 345?', 'answer': '41'}}\n","Size of array:  26\n","{'qa_pair1': {'question': 'What are the rules related to when a beneficiary is discharged from another facility?', 'answer': '42'}, 'qa_pair2': {'question': 'What is the sample IM form available at?', 'answer': '43'}, 'qa_pair3': {'question': 'What is the type of schema?', 'answer': 'object'}}\n","Size of array:  27\n","{'qa_pair1': {'question': 'What is the reason for the expedited review request?', 'answer': 'The beneficiary has requested an expedited review.'}, 'qa_pair2': {'question': 'What is the deadline for the hospital to provide information to the QIO?', 'answer': \"24 hours after the QIO's notification.\"}, 'qa_pair3': {'question': 'What is the burden of proof on the hospital to show that discharge is appropriate?', 'answer': 'The hospital must provide any and all information to make an expedited determination.'}}\n","Size of array:  28\n","{'qa_pair1': {'question': 'What is the name of the hospital?', 'answer': 'Hospital A'}, 'qa_pair2': {'question': 'What is the name of the beneficiary?', 'answer': 'Beneficiary A'}, 'qa_pair3': {'question': 'What is the date of the request?', 'answer': 'Requested on 2023-01-01'}}\n","Size of array:  29\n","{'qa_pair1': {'question': 'What is the deadline for the QIC to make a determination?', 'answer': '72 hours'}, 'qa_pair2': {'question': \"What are the beneficiary's rights if the QIC fails to make a determination within 72 hours?\", 'answer': 'Notify the beneficiary of their rights to file an appeal with the OMHA.'}, 'qa_pair3': {'question': 'What is the deadline for the QIC to make a determination if the beneficiary requests an extension?', 'answer': '14 days'}}\n","Size of array:  30\n","{'qa_pair1': {'question': 'What is the deadline for filing an appeal for a denied inpatient claim?', 'answer': '30 calendar days'}, 'qa_pair2': {'question': 'What is the Medicare Claims Processing Manual Ch. 30, section 200.4.2?', 'answer': 'Id. 47 Medicare Claims Processing Manual Ch. 30, section 200.4.2.'}, 'qa_pair3': {'question': 'What is the Medicare Claims Processing Manual Ch. 30, section 200.4.2?', 'answer': 'Id. 47 Medicare Claims Processing Manual Ch. 30, section 200.4.2.'}}\n","Size of array:  31\n","{'qa_pair1': {'question': 'What is the name of the hospital where Norman was discharged?', 'answer': 'Norman was discharged from the hospital.'}, 'qa_pair2': {'question': 'What is the name of the surgeon who Norman saw?', 'answer': 'Norman saw his surgeon for a follow-up appointment.'}, 'qa_pair3': {'question': 'What is the name of the procedure that Norman had?', 'answer': 'Norman had a surgical incision.'}}\n","Size of array:  32\n","{'qa_pair1': {'question': 'What is the expedited process outlined here for hospital discharge appeals?', 'answer': '54'}, 'qa_pair2': {'question': 'What is the additional 14-day extension if parties provide additional evidence after filing a redetermination?', 'answer': '55'}, 'qa_pair3': {'question': 'What is the additional 14-day extension if parties provide additional evidence after filing a redetermination?', 'answer': '55'}}\n","Size of array:  33\n","{'qa_pair1': {'question': 'What is the name of the program that operates Medicare Part C plans?', 'answer': 'Medicare (MA) Plans'}, 'qa_pair2': {'question': 'What percentage of beneficiaries will choose to enroll in an MA plan in 2021?', 'answer': '42 percent'}, 'qa_pair3': {'question': 'What methods do MA plans use to steer beneficiaries towards lower cost alternatives?', 'answer': 'Plans may what items to cover or may impose utilization management tools (like prior authorization or therapy) on drugs or services.'}}\n","Size of array:  34\n","{'qa_pair1': {'question': 'What is the name of the drug?', 'answer': 'Saxenda'}, 'qa_pair2': {'question': 'What is the name of the drug?', 'answer': 'Saxenda'}, 'qa_pair3': {'question': 'What is the name of the drug?', 'answer': 'Saxenda'}}\n","Size of array:  35\n","{'qa_pair1': {'question': 'What are the different types of Medicare Advantage plans?', 'answer': 'Medicare Advantage plans can be offered either as health maintenance organizations (HMOs), preferred provider organizations (PPOs), private fee-for-service (PFFS) plans, or special needs plans (SNPs). Most MA plans also offer prescription drug coverage.'}, 'qa_pair2': {'question': 'What is the difference between Medicare Part A and Part B?', 'answer': 'Medicare Part A and Part B are two separate parts of Medicare. Part A covers hospital stays, skilled nursing facility care, home health care, and hospice care. Part B covers outpatient services, such as doctor visits, lab tests, and medical equipment.'}, 'qa_pair3': {'question': 'What are the advantages of Medicare Advantage plans?', 'answer': 'Medicare Advantage plans can offer lower premiums and cost-sharing compared to traditional Medicare. They also offer additional benefits, such as prescription drug coverage and fitness programs.'}}\n","Size of array:  36\n","{'qa_pair1': {'question': 'What is the plan’s determination of whether to subject a particular drug to a PA requirement?', 'answer': 'not subject to appeal, though the enrollee may appeal the imposition of the UM tool in order to gain access to the drug or service.'}, 'qa_pair2': {'question': 'What is the Medicare rules regarding the calculation of timeframes and standard of review is the same for Medicare Part D plans?', 'answer': 'the Medicare rules regarding the calculation of timeframes and standard of review is the same for Medicare Part D plans.'}, 'qa_pair3': {'question': 'What is the Medicare rules regarding the calculation of timeframes and standard of review is the same for Medicare Part D plans?', 'answer': 'the Medicare rules regarding the calculation of timeframes and standard of review is the same for Medicare Part D plans.'}}\n","Size of array:  37\n","{'qa_pair1': {'question': 'When Medicare rules consider an MA plan to have officially received the request varies and generally favors the plan over the enrollee.', 'answer': 'generally favors the plan over the enrollee.'}, 'qa_pair2': {'question': 'For standard requests the MA plan’s timeframe begins when any unit in the plan, or a delegated entity (including a delegated entity that is not responsible for processing requests) receives the request.', 'answer': 'generally favors the plan over the enrollee.'}, 'qa_pair3': {'question': 'Plans can also provide verbal notification, which is considered to be delivered on the date and time the plan speaks to the enrollee.', 'answer': 'generally favors the plan over the enrollee.'}}\n","Size of array:  38\n","{'qa_pair1': {'question': 'What is the best decision a plan can make if they do not receive any additional information from a provider?', 'answer': 'Make reasonable and diligent efforts to obtain all necessary information.'}, 'qa_pair2': {'question': 'What is the best decision a plan can make if they do not receive any additional information from a provider?', 'answer': 'Make reasonable and diligent efforts to obtain all necessary information.'}, 'qa_pair3': {'question': 'What is the best decision a plan can make if they do not receive any additional information from a provider?', 'answer': 'Make reasonable and diligent efforts to obtain all necessary information.'}}\n","Size of array:  39\n","{'qa_pair1': {'question': 'What is the difference between MA plans and Medicare contractors (MACs) in processing claims and determining appeals?', 'answer': 'MA plans make their own'}, 'qa_pair2': {'question': 'What is the difference between MA plans and Medicare contractors (MACs) in processing claims and determining appeals?', 'answer': 'MA plans can choose to use a network of providers and require beneficiaries to undergo utilization management services before seeking treatment.'}, 'qa_pair3': {'question': 'What is the difference between MA plans and Medicare contractors (MACs) in processing claims and determining appeals?', 'answer': 'MA plans can also choose to use a network of providers and require beneficiaries to undergo utilization management services before seeking treatment.'}}\n","Size of array:  40\n","{'qa_pair1': {'question': 'What is the deadline for requesting information from a non-contract provider?', 'answer': '24 hours'}, 'qa_pair2': {'question': 'What is the deadline for requesting information from a non-contract provider?', 'answer': '24 hours'}, 'qa_pair3': {'question': 'What is the deadline for requesting information from a non-contract provider?', 'answer': '24 hours'}}\n","Size of array:  41\n","{'qa_pair1': {'question': 'What is the process for filing an appeal?', 'answer': 'The process for filing an appeal is to submit a written appeal, though standard appeals may be submitted verbally (depending on the plan). MA plans must accept verbal expedited appeals.'}, 'qa_pair2': {'question': 'What is the process for expedited verbal appeals?', 'answer': 'MA plans have the option to accept verbal expedited appeals.'}, 'qa_pair3': {'question': 'What is the process for filing an appeal in writing?', 'answer': 'MA plans must accept written appeals.'}}\n","Size of array:  42\n","{'qa_pair1': {'question': 'What is the level 1 appeal process for MA plans?', 'answer': 'The level 1 appeal process for MA plans is administered by the MA plan but must be conducted by someone other than making the initial determination. If the initial determination was based on a lack of medical then the level 1 appeal must be administered by a physician with expertise related to the on appeal. The physician performing the reconsideration must apply a prudent layperson in cases involving urgently needed or emergency services.'}, 'qa_pair2': {'question': 'What is the prudent layperson standard in MA plans?', 'answer': 'The prudent layperson standard in MA plans is applied by the physician performing the reconsideration. The physician must apply a prudent layperson standard in cases involving urgently needed or emergency services.'}, 'qa_pair3': {'question': 'What is the level 1 appeal process for MA plans?', 'answer': 'The level 1 appeal process for MA plans is administered by the MA plan but must be conducted by someone other than making the initial determination. If the initial determination was based on a lack of medical then the level 1 appeal must be administered by a physician with expertise related to the on appeal. The physician performing the reconsideration must apply a prudent layperson standard in cases involving urgently needed or emergency services.'}}\n","Size of array:  43\n","{'qa_pair1': {'question': 'What is the timeframe for standard her request to see the pre-service and expedited reconsiderations for items and network specialist services, in certain limited instances?', 'answer': '80 (However, Part B drug timeframes may not be extended.) MA plans that choose to extend the timeframe must notify enrollee.'}, 'qa_pair2': {'question': 'What is the timeframe for standard her request to see the pre-service and expedited reconsiderations for items and network specialist services, in certain limited instances?', 'answer': '80 (However, Part B drug timeframes may not be extended.) MA plans that choose to extend the timeframe must notify enrollee.'}, 'qa_pair3': {'question': 'What is the timeframe for standard her request to see the pre-service and expedited reconsiderations for items and network specialist services, in certain limited instances?', 'answer': '80 (However, Part B drug timeframes may not be extended.) MA plans that choose to extend the timeframe must notify enrollee.'}}\n","Size of array:  44\n","{'qa_pair1': {'question': \"What is the MA plan's timeframe for making a decision?\", 'answer': 'The MA plan must make a decision within 30 days.'}, 'qa_pair2': {'question': \"What is the MA plan's timeframe for forwarding a decision to the Independent Review Entity?\", 'answer': 'The MA plan must forward a decision to the Independent Review Entity within 30 days.'}, 'qa_pair3': {'question': \"What is the MA plan's timeframe for providing notice to the enrollee that the decision has been forwarded to the Independent Review Entity?\", 'answer': 'The MA plan must provide notice to the enrollee within 30 days.'}}\n","Size of array:  45\n","{'qa_pair1': {'question': '77 Part C&D Appeals Guidance, section 50.6. However, this does not mean that the physician reviewing the case must have the same specialty training as the prescribing physician. Medicare only requires that the reviewing physician have \\\\', 'answer': 'Medicare only requires that the reviewing physician have \\\\'}, 'qa_pair2': {'question': 'Generate a highly contextual question and answer pairs from the following context', 'answer': 'Avoid leading questions, or questions with the answer explicitly in them'}, 'qa_pair3': {'question': 'Each question must be unique with no duplicates', 'answer': 'Each answer must be unique with no duplicates'}}\n","Size of array:  46\n","{'qa_pair1': {'question': \"What is the independent reviewer's denial of Carla's out-of-network coverage request?\", 'answer': \"The independent reviewer denied Carla's out-of-network coverage request.\"}, 'qa_pair2': {'question': \"What are Carla's options to appeal the decision?\", 'answer': \"Carla has the option to appeal the decision through the independent reviewer's office.\"}, 'qa_pair3': {'question': 'How long will Carla have to wait to be treated?', 'answer': 'Carla is unsure how long she will have to wait to be treated.'}}\n","Size of array:  47\n","{'qa_pair1': {'question': 'What is the amount in controversy threshold amounts for 2020?', 'answer': 'The amount shown in this table reflect the threshold amount for 2020.'}, 'qa_pair2': {'question': 'What is the amount in controversy threshold amounts for 2020?', 'answer': 'The amount shown in this table reflect the threshold amount for 2020.'}, 'qa_pair3': {'question': 'What is the amount in controversy threshold amounts for 2020?', 'answer': 'The amount shown in this table reflect the threshold amount for 2020.'}}\n","Size of array:  48\n","{'qa_pair1': {'question': 'What is the term \\\\', 'answer': 'pre-service'}, 'qa_pair2': {'question': 'What is the amount in controversy?', 'answer': '170'}, 'qa_pair3': {'question': 'What is the time in controversy?', 'answer': '180 days'}}\n","Size of array:  49\n","{'qa_pair1': {'question': 'What is Medicare Part D?', 'answer': 'Medicare Part D covers outpatient prescription drugs.'}, 'qa_pair2': {'question': 'How does Medicare Part D work?', 'answer': 'Medicare Part D is operated by private plans that often use various methods to steer beneficiaries lower cost alternatives.'}, 'qa_pair3': {'question': 'What are some examples of utilization management tools used by Medicare Part D plans?', 'answer': 'Plans may choose what items to cover or impose utilization management tools (like prior authorization or step therapy) on drugs or services.'}}\n","Size of array:  50\n","{'qa_pair1': {'question': 'What is the process for an enrollee to request an expedited determination if medically warranted?', 'answer': 'Enrollees can request an expedited determination if medically warranted.92 Part D plans are permitted to deny a request for expedited timeframe. However, upon doing so they must transfer the request to the standard initial determination process; give the enrollee prompt verbal response; and deliver written notice within three calendar days of the verbal notice.'}, 'qa_pair2': {'question': 'What is the process for a Part D plan to deny a request for expedited timeframe?', 'answer': 'Upon doing so they must transfer the request to the standard initial determination process; give the enrollee prompt verbal response; and deliver written notice within three calendar days of the verbal notice.'}, 'qa_pair3': {'question': 'What is the process for a Part D plan to transfer a request for expedited timeframe?', 'answer': 'Upon doing so they must transfer the request to the standard initial determination process; give the enrollee prompt verbal response; and deliver written notice within three calendar days of the verbal notice.'}}\n","Size of array:  51\n","{'qa_pair1': {'question': 'What is the process for prior authorization or other utilization management requirements?', 'answer': 'Part D plans often use prior authorization or other utilization management tools in order to shift enrollee behavior.'}, 'qa_pair2': {'question': 'What is the initial determination when a plan processes a request for prior authorization or other utilization management requirements?', 'answer': 'When a plan processes a request for prior authorization (PA) or other utilization management (UM) requirements, it is considered an initial determination and is subject to appeal.'}, 'qa_pair3': {'question': 'What is the process for subjecting a drug to an UM requirement?', 'answer': 'Part D plans may place a drug on a PA list or subject it to another UM requirement. The Part D determination on whether to subject a drug to an UM requirement is not subject to appeal.'}}\n","Size of array:  52\n","{'qa_pair1': {'question': 'What is the minimum amount in controversy for a Medicare Part D request to be expedited?', 'answer': 'The amount in controversy must be at least $1,670, which is the 2020 minimum amount.'}, 'qa_pair2': {'question': 'What is the Medicare Part D standard timeframe?', 'answer': \"The Part D plan determines that applying the standard timeframe could seriously jeopardize the life or health of the enrollee or the enrollee's ability to maximum function.\"}, 'qa_pair3': {'question': 'What is the Part C&D Appeals Guidance, section 40.8?', 'answer': 'Part C&D Appeals Guidance, section 40.8.'}}\n","Size of array:  53\n","{'qa_pair1': {'question': 'What is the name of the drug?', 'answer': 'XYZ'}, 'qa_pair2': {'question': 'What is the generic name of the drug?', 'answer': 'XYZ'}, 'qa_pair3': {'question': 'What is the cost of the drug?', 'answer': 'XYZ'}}\n","Size of array:  54\n","{'qa_pair1': {'question': \"What is the name of the drug that Cliff's requirement related to a specific drug?\", 'answer': 'Clarithromycin'}, 'qa_pair2': {'question': \"What is the name of the drug that Cliff's requirement related to a specific drug?\", 'answer': 'Clarithromycin'}, 'qa_pair3': {'question': \"What is the name of the drug that Cliff's requirement related to a specific drug?\", 'answer': 'Clarithromycin'}}\n","Size of array:  55\n","{'qa_pair1': {'question': 'What is the name of the drug?', 'answer': 'A drug'}, 'qa_pair2': {'question': 'Why is the drug medically necessary?', 'answer': 'The drug is not as effective or has adverse effects.'}, 'qa_pair3': {'question': 'What alternatives in the formulary have been ineffective or have adverse effects to the enrollee?', 'answer': 'None.'}}\n","Size of array:  56\n","{'qa_pair1': {'question': 'What is the name of the lowest cost-sharing tier for biologics?', 'answer': 'Tier 1'}, 'qa_pair2': {'question': 'What is the name of the highest cost-sharing tier?', 'answer': 'Tier 3'}, 'qa_pair3': {'question': 'What is the name of the lowest cost-sharing tier for generics?', 'answer': 'Tier 2'}}\n","Size of array:  57\n","{'qa_pair1': {'question': 'What is the most common reason for a Part D plan to deny coverage for a prescription?', 'answer': 'Enrollees presenting a prescription at a pharmacy counter may encounter problems obtaining the prescription – for example, if the drug is not covered under the Part D plan’s formulary or if it is subject to a PA or other UM requirement.'}, 'qa_pair2': {'question': 'What is the process for filing a separate request for a coverage determination?', 'answer': 'As a result, enrollees are not provided a written denial notice at the pharmacy and must file a separate request for a coverage determination.'}, 'qa_pair3': {'question': 'What is the process for Part D plan sponsors to arrange with network or preferred pharmacies to provide enrollees with a written copy of a standardized pharmacy notice if the prescription is unable to be filled at the point of sale?', 'answer': 'Part D plan sponsors must arrange with network or preferred pharmacies to provide enrollees with a written copy of a standardized \\\\u2013 not individualized to the beneficiary \\\\u2013 pharmacy notice if the prescription is unable to be filled at the point of sale.'}}\n","Size of array:  58\n","{'qa_pair1': {'question': 'What is the start of the timeframe for the adjudication of a request for benefits?', 'answer': \"The start of the timeframe for the adjudication of a request for benefits is tolled until the Part D Plan receives the prescriber's supporting statement.\"}, 'qa_pair2': {'question': 'What is the type of request?', 'answer': 'The request is at the coverage determination level.'}, 'qa_pair3': {'question': 'What is the type of request?', 'answer': 'The request involves an exception.'}}\n","Size of array:  59\n","{'qa_pair1': {'question': 'What is the category of the request?', 'answer': 'closed_qa'}, 'qa_pair2': {'question': 'What is the timeframe for additional information?', 'answer': '14 calendar days'}, 'qa_pair3': {'question': \"What is the timeframe for the Part D plan's decision?\", 'answer': '72 hours for a standard request, 24 hours in cases'}}\n","Size of array:  60\n","{'qa_pair1': {'question': 'What is the transition process for new enrollees prior to enrolling in the plan?', 'answer': \"D plans must abide by transition process for new enrollees prior to enrolling in the plan, have been stabilized on a formulary that is not on the plan's formulary or is subject to management requirement.\"}, 'qa_pair2': {'question': 'What happens if the enrollee in this period files an exceptions request regarding the drug the Part D plan fails to respond in a timely manner and/or to forward the request to the IRE?', 'answer': 'If the Part D plan fails to respond in a timely manner and/or to forward the request to the IRE, the enrollee must be provided with a temporary supply of the drug until the Part D plan responds.'}, 'qa_pair3': {'question': 'What happens if the Part D plan fails to respond in a timely manner and/or to forward the request to the IRE?', 'answer': 'If the Part D plan fails to respond in a timely manner and/or to forward the request to the IRE, the enrollee must be provided with a temporary supply of the drug until the Part D plan responds.'}}\n","Size of array:  61\n","{'qa_pair1': {'question': 'What is the standard appeals process for Part D plans?', 'answer': 'Standard appeals must be submitted in writing.'}, 'qa_pair2': {'question': 'What is the option for Part C plans to accept appeals via web/internet?', 'answer': 'Part C plans have the option to accept appeals via web/internet.'}, 'qa_pair3': {'question': 'What is the requirement for Part D plans to accept appeals via web/internet?', 'answer': 'Part D plans must accept appeals via web/internet.'}}\n","Size of array:  62\n","{'qa_pair1': {'question': 'What is the name of the appeal?', 'answer': 'Level 1 appeal'}, 'qa_pair2': {'question': 'What is the name of the Part D Plan?', 'answer': 'Part D Plan'}, 'qa_pair3': {'question': 'What is the name of the enrollee?', 'answer': 'Enrollee'}}\n","Size of array:  63\n","{'qa_pair1': {'question': 'What is the level 1 appeal process for a denied initial determination?', 'answer': 'The level 1 appeal process for a denied initial determination is administered by a physician with expertise related to the issue on appeal.'}, 'qa_pair2': {'question': 'What is the level 1 appeal process for a denied initial determination?', 'answer': 'The level 1 appeal process for a denied initial determination is administered by a physician with expertise related to the issue on appeal.'}, 'qa_pair3': {'question': 'What is the level 1 appeal process for a denied initial determination?', 'answer': 'The level 1 appeal process for a denied initial determination is administered by a physician with expertise related to the issue on appeal.'}}\n","Size of array:  64\n","{'qa_pair1': {'question': 'What is the appropriate level of training and expertise required to evaluate the necessity of the requested drug?', 'answer': 'The appropriate level of training and expertise required to evaluate the necessity of the requested drug is determined by Medicare, and does not necessarily have to be the same specialty training as the prescribing physician.'}, 'qa_pair2': {'question': 'What is the opportunity to present additional evidence in expedited appeals?', 'answer': 'In expedited appeals, the opportunity to present additional evidence may be limited by the short timeframe the Part D Plan has in making a decision. In such cases, the Part D Plan must inform all parties (enrollee/prescriber) of the conditions for submitting evidence.'}, 'qa_pair3': {'question': 'What is the appropriate level of training and expertise required to evaluate the necessity of the requested drug?', 'answer': 'The appropriate level of training and expertise required to evaluate the necessity of the requested drug is determined by Medicare, and does not necessarily have to be the same specialty training as the prescribing physician.'}}\n","Size of array:  65\n","{'qa_pair1': {'question': 'What is the deadline for a Part D plan to inform the IRE of a timely decision failure?', 'answer': '24 hours'}, 'qa_pair2': {'question': 'What is the deadline for a Part D plan to forward expedited cases to the IRE?', 'answer': '24 hours'}, 'qa_pair3': {'question': 'What is the deadline for a Part D plan to forward standard cases to the IRE?', 'answer': '48 hours'}}\n","Size of array:  66\n","{'qa_pair1': {'question': 'What is the deadline for filing an appeal with the IRE for reconsideration?', 'answer': '60 days'}, 'qa_pair2': {'question': 'What is the timeframe for expedited consideration?', 'answer': '60 days'}, 'qa_pair3': {'question': 'What is the timeframe for standard consideration?', 'answer': '60 days'}}\n","Size of array:  67\n","{'qa_pair1': {'question': 'What is the deadline for requesting an IRE reconsideration?', 'answer': '60 days'}, 'qa_pair2': {'question': 'What is the difference between Part C and Part D appeals guidance?', 'answer': 'Part C&D Appeals Guidance, section 50.12.2.'}, 'qa_pair3': {'question': 'What is the difference between a partially favorable or adverse reconsideration decision and a Level appeal?', 'answer': 'Part C, in which a party does not have to make a request for a Level appeal (all partially favorable or adverse reconsideration decisions are forwarded to the IRE).'}}\n","Size of array:  68\n","{'qa_pair1': {'question': 'What is the deadline for filing an appeal?', 'answer': '120 days'}, 'qa_pair2': {'question': 'What is the deadline for filing an appeal?', 'answer': '120 days'}, 'qa_pair3': {'question': 'What is the deadline for filing an appeal?', 'answer': '120 days'}}\n","Size of array:  69\n","{'qa_pair1': {'question': 'What is the amount in controversy threshold amounts for 2020?', 'answer': 'The amount shown in this table reflect the amount for 2020.'}, 'qa_pair2': {'question': 'What is the amount in controversy threshold amounts for 2021?', 'answer': 'The amount shown in this table reflect the amount for 2021.'}, 'qa_pair3': {'question': 'What is the amount in controversy threshold amounts for 2022?', 'answer': 'The amount shown in this table reflect the amount for 2022.'}}\n","Size of array:  70\n","{'qa_pair1': {'question': \"What is Cliff's medication situation?\", 'answer': 'Cliff is lucky. After one more round of appeals, his heart medication is approved. But thanks to the complicated process, he ended up waiting 2 weeks to start taking his lung cancer medication and over 3 months to start taking the heart medication.'}, 'qa_pair2': {'question': \"What is the impact of Cliff's medication situation?\", 'answer': \"Cliff's health continued to deteriorate, and he had to make an expensive trip to the ER, which might have been avoided if he had quicker access to his medications.\"}, 'qa_pair3': {'question': \"What is the impact of Cliff's medication situation on his health?\", 'answer': \"Cliff's health continued to deteriorate, and he had to make an expensive trip to the ER, which might have been avoided if he had quicker access to his medications.\"}}\n","Size of array:  71\n","{'qa_pair1': {'question': 'What is the Medicare Appeals process?', 'answer': 'The Medicare Appeals process is a way for Medicare beneficiaries to appeal decisions made by Medicare about coverage, payment, or service.'}, 'qa_pair2': {'question': 'What is the Medicare Appeals process?', 'answer': 'The Medicare Appeals process is a way for Medicare beneficiaries to appeal decisions made by Medicare about coverage, payment, or service.'}, 'qa_pair3': {'question': 'What is the Medicare Appeals process?', 'answer': 'The Medicare Appeals process is a way for Medicare beneficiaries to appeal decisions made by Medicare about coverage, payment, or service.'}}\n","Size of array:  72\n","{'qa_pair1': {'question': 'Are private and contractors at a disadvantage because of their lack of familiarity with the system?', 'answer': 'Yes, they have an advantage given their with the program and expertise regarding appeals.'}, 'qa_pair2': {'question': 'Given the number of filed each year, this number excludes those individuals who did not engage in the appeals either because they are not made aware of its existence or because they feel by the process.', 'answer': 'True.'}, 'qa_pair3': {'question': 'What is the number of filed each year?', 'answer': 'The number of filed each year is not made available by Medicare.'}}\n","Size of array:  73\n","{'qa_pair1': {'question': 'What is the process for expedited appeals for beneficiaries who are undergoing a health event?', 'answer': 'The appeals process for beneficiaries who are undergoing a health event is expedited to ensure that they receive the benefits they are entitled to as soon as possible.'}, 'qa_pair2': {'question': 'What are the benefits of expedited appeals for beneficiaries who are undergoing a health event?', 'answer': 'The benefits of expedited appeals for beneficiaries who are undergoing a health event include receiving the benefits they are entitled to as soon as possible, and having the appeals process be more manageable and less cumbersome.'}, 'qa_pair3': {'question': 'What are the requirements for expedited appeals for beneficiaries who are undergoing a health event?', 'answer': 'The requirements for expedited appeals for beneficiaries who are undergoing a health event include that the beneficiary is undergoing a health event, that they are unable to physically contend with the appeals process, and that they have no immediate family members, friends, or caregivers who can assist them.'}}\n","Size of array:  74\n","{'qa_pair1': {'question': 'What is the number of levels of review for Medicare beneficiaries?', 'answer': 'There are 3 levels of review for Medicare beneficiaries.'}, 'qa_pair2': {'question': 'What is the potential impact of the timeframes for each level of review on access to medically appropriate products or services?', 'answer': 'The potential impact is that beneficiaries may not have access to a needed product or service for several days, if not weeks (depending on how many levels of review are undergone).'}, 'qa_pair3': {'question': 'What is the impact of Medicare Advantage or Part D plans on cancer care?', 'answer': 'The impact is that providers report delays in cancer care because of having to wait for Medicare Advantage or Part D plans to overturn utilization management tools.'}}\n","Size of array:  75\n","{'qa_pair1': {'question': 'plan', 'answer': 'impartiality'}, 'qa_pair2': {'question': 'appeals process', 'answer': 'streamlined'}, 'qa_pair3': {'question': 'appeals process', 'answer': 'handled by a neutral third'}}\n","Size of array:  76\n","{'qa_pair1': {'question': 'What is the process for filing an appeal with respect to coverage about products or services provided under the Medicare program?', 'answer': 'Medicare has different rules and regulations depending on the beneficiary is filing an inquiry, grievance, or request for coverage.'}, 'qa_pair2': {'question': 'What are the different types of appeals that Medicare beneficiaries have the right to file?', 'answer': 'Medicare has different rules and regulations depending on the beneficiary is filing an inquiry, grievance, or request for coverage.'}, 'qa_pair3': {'question': 'What are the different types of inquiries, grievances, and requests for coverage that Medicare beneficiaries have the right to file?', 'answer': 'Medicare has different rules and regulations depending on the beneficiary is filing an inquiry, grievance, or request for coverage.'}}\n","Size of array:  77\n","{'qa_pair1': {'question': 'What is the coverage for [item/service]?', 'answer': 'Please provide more information.'}, 'qa_pair2': {'question': 'What is the coverage for [item/service]?', 'answer': 'Please provide more information.'}, 'qa_pair3': {'question': 'What is the coverage for [item/service]?', 'answer': 'Please provide more information.'}}\n","Size of array:  78\n","{'qa_pair1': {'question': 'What is the appeal process for the program?', 'answer': 'The appeal process for the program is based on a closed-question and answer format.'}, 'qa_pair2': {'question': 'What is the appeal process for the program?', 'answer': 'The appeal process for the program is based on a closed-question and answer format.'}, 'qa_pair3': {'question': 'What is the appeal process for the program?', 'answer': 'The appeal process for the program is based on a closed-question and answer format.'}}\n","Size of array:  79\n","{'qa_pair1': {'question': 'What is the Medicare appeals process?', 'answer': 'The Medicare appeals process is the process by which beneficiaries can appeal decisions made by Medicare about coverage, payment, or services.'}, 'qa_pair2': {'question': 'How can Medicare improve the appeals process for beneficiaries?', 'answer': 'Medicare should review its standard denial notices, including those provided by MA and Part D plans, to ensure that the notices are provided to beneficiaries in languages other than English and are accessible to people with diverse health literacy levels. As part of this process, Medicare should consult with beneficiary- and patient-advocacy organizations on ways to improve clarity in the program for beneficiaries and consider consumer testing of the notices. Medicare should also consider providing beneficiaries with the option to appeal decisions made by Medicare through a process that is more accessible and understandable for beneficiaries with diverse health literacy levels.'}, 'qa_pair3': {'question': 'What are some specific ways that Medicare can improve the appeals process?', 'answer': 'Medicare can consider providing beneficiaries with the option to appeal decisions made by Medicare through a process that is more accessible and understandable for beneficiaries with diverse health literacy levels. Medicare can also consider providing beneficiaries with the option to appeal decisions made by Medicare through a process that is more accessible and understandable for beneficiaries with diverse health literacy levels. Medicare can also consider providing beneficiaries with the option to appeal decisions made by Medicare through a process that is more accessible and understandable for beneficiaries with diverse health literacy levels.'}}\n","Size of array:  80\n","{'qa_pair1': {'question': 'What is a grievance?', 'answer': \"A grievance is an enrollee's dissatisfaction with any aspect of the operation of the plan.\"}, 'qa_pair2': {'question': 'What is a coverage request?', 'answer': \"A coverage request is an enrollee's request for coverage of specific items or services.\"}, 'qa_pair3': {'question': 'What is the difference between a grievance and a coverage request?', 'answer': 'A grievance and a coverage request are two separate issues that should be separately processed under the appropriate procedure.'}}\n","Size of array:  81\n","{'qa_pair1': {'question': 'What is the Medicare program requirement for plans to comply with the rules and requirements concerning the appeals process?', 'answer': 'Plans must comply with the rules and requirements concerning the appeals process, including the timelines, as a condition of their contract with the Medicare program.'}, 'qa_pair2': {'question': 'What is the Medicare program requirement for plans to perform self-audits to that certain processes are being followed?', 'answer': 'Plans must perform self-audits to that certain processes are being followed.'}, 'qa_pair3': {'question': 'What is the Medicare program requirement for plans to devote significant resources to oversee that plans are complying with these requirements?', 'answer': 'Plans must devote significant resources to oversee that plans are complying with these requirements.'}}\n","Size of array:  82\n","{'qa_pair1': {'question': 'What is the maximum number of Part C and D plans that CMS audits each year?', 'answer': '132'}, 'qa_pair2': {'question': 'What is the authority of CMS to impose sanctions, civil monetary penalties, and terminate plans that are not in compliance?', 'answer': 'CMS has the authority to impose sanctions, civil monetary penalties, and can terminate plans that are not in compliance.'}, 'qa_pair3': {'question': 'What is the output result in the following JSON schema format?', 'answer': '{'}}\n","Size of array:  83\n","{'qa_pair1': {'question': 'What is the Medicare program?', 'answer': 'The Medicare program is a federal health insurance program for people 65 and older and people with certain disabilities.'}, 'qa_pair2': {'question': 'What is the time frame for Medicare decisions?', 'answer': 'Medicare decisions must be made within a certain time frame.'}, 'qa_pair3': {'question': 'What is the Office of Medicare Hearings and Appeals?', 'answer': 'The Office of Medicare Hearings and Appeals is responsible for reviewing Medicare decisions.'}}\n","Size of array:  84\n","{'qa_pair1': {'question': \"What are the beneficiaries' rights to appeal?\", 'answer': 'The Medicare program provides a Medicare & You handbook each year that it provides to beneficiaries, but not all keep a copy of this handbook and may not recall that it contains information about their rights to appeal.'}, 'qa_pair2': {'question': 'What is the Medicare program?', 'answer': 'The Medicare program is a federal health insurance program for people 65 years old or older, certain younger people with disabilities, and people with end-stage renal disease.'}, 'qa_pair3': {'question': 'What is the Medicare & You handbook?', 'answer': \"The Medicare & You handbook provides information about Medicare and Medicare-related programs, including information about beneficiaries' rights to appeal.\"}}\n","Size of array:  85\n","{'qa_pair1': {'question': 'What is the Medicare appeals process?', 'answer': 'The Medicare appeals process is a way for Medicare beneficiaries to appeal decisions made by the Medicare program.'}, 'qa_pair2': {'question': 'What is the State Health Insurance Program (SHIP) and how can it help with Medicare appeals?', 'answer': 'The State Health Insurance Program (SHIP) is a program that provides one-on-one assistance to Medicare beneficiaries on a wide variety of issues, including appeals. This program is vitally important to beneficiaries, but funding for the program – which relies on a highly trained volunteer workforce – is not sufficient.'}, 'qa_pair3': {'question': 'What are the qualifications for becoming a SHIP counselor?', 'answer': 'To become a SHIP counselor, you must be a Medicare beneficiary who has successfully completed a training program and passed a background check.'}}\n","Size of array:  86\n","{'qa_pair1': {'question': 'What is the Medicare appeals program?', 'answer': 'The Medicare appeals program is a process for reviewing decisions made by Medicare about coverage, payment, or service.'}, 'qa_pair2': {'question': 'What is the Medicare appeals program?', 'answer': 'The Medicare appeals program is a process for reviewing decisions made by Medicare about coverage, payment, or service.'}, 'qa_pair3': {'question': 'What is the Medicare appeals program?', 'answer': 'The Medicare appeals program is a process for reviewing decisions made by Medicare about coverage, payment, or service.'}}\n","Size of array:  87\n","{'qa_pair1': {'question': 'What is the process for Medicare to determine whether a beneficiary is eligible for Medicare?', 'answer': \"Medicare determines eligibility based on a beneficiary's age, disability, and financial status.\"}, 'qa_pair2': {'question': 'What is the geographic variation in appeals filed?', 'answer': 'Medicare does not have data on geographic variation in appeals filed.'}, 'qa_pair3': {'question': 'What are the specific diseases or conditions that are subject to more appeals?', 'answer': 'Medicare does not have data on specific diseases or conditions that are subject to more appeals.'}}\n","Size of array:  88\n","{'qa_pair1': {'question': 'What is the process for appealing a Medicare denial?', 'answer': 'The Medicare appeals process is a formal review of a Medicare denial. You can appeal a Medicare denial by submitting a written request to the Medicare contractor that made the denial. You can also appeal a Medicare denial by requesting a hearing before an administrative law judge (ALJ).'}, 'qa_pair2': {'question': 'What is the difference between an appeal and a hearing?', 'answer': 'An appeal is a formal review of a Medicare denial. It allows you to ask Medicare to review the decision and reconsider it. An appeal does not automatically lead to a hearing. A hearing is a formal review of a Medicare denial. It allows you to present evidence and argue your case before an ALJ. If the ALJ decides in your favor, Medicare must pay for the services that were denied. If the ALJ decides against you, you can appeal the decision to the Medicare Appeals Council.'}, 'qa_pair3': {'question': 'What is the timeline for appealing a Medicare denial?', 'answer': 'The Medicare appeals process can take several months to complete. You will receive a written decision from Medicare after the hearing or appeal is completed. If you disagree with the decision, you can appeal it to the Medicare Appeals Council.'}}\n","Size of array:  89\n","{'qa_pair1': {'question': 'Why am I unable to access my prescription?', 'answer': 'The Medicare Part D program covers outpatient prescription drugs and is administered by private plans. Some beneficiaries may go to the pharmacy and encounter a problem with respect to their prescription drugs – for example, when the prescription cannot be filled because the drug is not on the plan’s formulary or it requires an exception to the utilization management process.'}, 'qa_pair2': {'question': 'What should I do if I encounter a problem with my prescription?', 'answer': 'If you encounter a problem with your prescription, you should contact your Medicare Part D plan or the pharmacy directly. They may be able to help you resolve the issue.'}, 'qa_pair3': {'question': 'What is the Medicare Part D formulary?', 'answer': 'The Medicare Part D formulary is a list of prescription drugs that are covered by the Medicare Part D program. It is managed by the Medicare Part D plan and may change over time.'}}\n","Size of array:  90\n","{'qa_pair1': {'question': 'What is the opportunity for beneficiaries to request a tiering exception?', 'answer': 'Currently, beneficiaries are able to file a tiering exceptions request, which would allow the to obtain a non-preferred drug that resides in a higher tier at a lower cost-sharing applicable to in a lower cost-sharing tier.'}, 'qa_pair2': {'question': 'What drugs are not subject to tiering exceptions?', 'answer': 'Unfortunately, most beneficiaries are not aware of their opportunity to request a tiering exception. Also, drugs that reside on the specialty tier are not subject to tiering exceptions.'}, 'qa_pair3': {'question': 'What are the most expensive drugs?', 'answer': 'These drugs have the highest cost-sharing and are the most expensive.'}}\n","Size of array:  91\n","{'qa_pair1': {'question': 'What is the current Part D appeals program?', 'answer': \"The current Part D appeals program can result in beneficiaries' delayed access to Part drugs.\"}, 'qa_pair2': {'question': 'What is the percentage of preauthorization and payment denials appealed by Medicare Advantage plans?', 'answer': 'The report found that enrollees and providers appealed roughly one percent of preauthorization and payment denials, but among those that were appealed, Medicare Advantage plans overturned 75 percent of their own denials.'}, 'qa_pair3': {'question': 'What is the default of MA plans to deny claims, regardless of medical necessity?', 'answer': \"This data is concerning in that it suggests that MA plans' default is to deny claims, regardless of medical necessity.\"}}\n","Size of array:  92\n","{'qa_pair1': {'question': 'What is the name of the U.S. Department of Health and Human Services (HHS) office responsible for investigating Medicare Part D claims?', 'answer': 'Office of Inspector General (OIG)'}, 'qa_pair2': {'question': 'What is the name of the Medicare Part D beneficiary who faces extra steps that can delay or prevent access to prescribed drugs?', 'answer': '136 U.S. Department of Health and Human Services-Office of Inspector General (OIG)'}, 'qa_pair3': {'question': 'What is the name of the Medicare Part D beneficiary who faces extra steps that can delay or prevent access to prescribed drugs?', 'answer': '136 U.S. Department of Health and Human Services-Office of Inspector General (OIG)'}}\n","Size of array:  93\n","{'qa_pair1': {'question': \"What is the long-term impact of CMS's temporary flexibility in the Medicare appeals process?\", 'answer': 'It is unclear.'}, 'qa_pair2': {'question': \"What is the long-term impact of CMS's temporary flexibility in the Medicare appeals process on beneficiary access?\", 'answer': 'It may necessitate.'}, 'qa_pair3': {'question': \"What is the long-term impact of CMS's temporary flexibility in the Medicare appeals process on the long-term ramifications of such flexibility?\", 'answer': 'It remains unclear.'}}\n","Size of array:  94\n","{'qa_pair1': {'question': \"What is the Medicare program's reliance on the United States Postal Service (USPS) for notification to beneficiaries of information regarding their appeals?\", 'answer': 'The Medicare program relies on the United States Postal Service (USPS) to serve as a means of notification to beneficiaries of information regarding their appeals – both in terms of timeframes by which plan responses are due and a means by which beneficiaries can communicate with their plans.'}, 'qa_pair2': {'question': 'What are the delays in mail service experienced by the USPS?', 'answer': 'Unfortunately, the USPS has experienced significant delays, and mail service is not functioning as expected.'}, 'qa_pair3': {'question': \"What is the impact of these delays on beneficiaries' ability to communicate with their plans?\", 'answer': 'The impact of these delays is that beneficiaries may not receive timely notifications regarding their appeals, and may have difficulty communicating with their plans.'}}\n","Size of array:  95\n"]}],"source":["create_dataset(model=\"OpenAssistant/falcon-7b-sft-mix-2000\",\n","               tokenizer=\"OpenAssistant/falcon-7b-sft-mix-2000\",\n","               file_path=\"example-docs/Medicare Appeals Paper FINAL.pdf\",\n","               output_path=\"./output.json\",\n","               load_in_4bit=True)"]},{"cell_type":"markdown","source":["## Thanks for the quickstart, what's next?\n","\n","We're still in beta so any feedback, pull requests, etc. would be appreciated. Leave us a star on our [github](https://github.com/kw2828/Guardrail-ML) and stay tuned for more tutorials.\n","\n","If you want to bring your LLM prototypes to production by mitigating AI risks, host this on your own infrastructure (e.g. VPC or on premise), or other enterprise features, [please contact us](https://www.useguardrail.com)."],"metadata":{"id":"eoGsjoWl2LMB"}}],"metadata":{"accelerator":"GPU","colab":{"provenance":[{"file_id":"1KCn1HIeD3fQy8ecT74yHa3xgJZvdNvqL","timestamp":1691608020196},{"file_id":"1isq_Oah3RNbNelJyhiSYe6lTZP8rEzcn","timestamp":1689204060471},{"file_id":"1B-oiJZ-YDDoH9IM8Ir9eEkakLfhHELPR","timestamp":1689161210231}]},"kernelspec":{"display_name":"Python 3","name":"python3"},"language_info":{"name":"python"},"widgets":{"application/vnd.jupyter.widget-state+json":{"23dc07661a0547e794b7a297640a79d0":{"model_module":"@jupyter-widgets/controls","model_name":"HBoxModel","model_module_version":"1.5.0","state":{"_dom_classes":[],"_model_module":"@jupyter-widgets/controls","_model_module_version":"1.5.0","_model_name":"HBoxModel","_view_count":null,"_view_module":"@jupyter-widgets/controls","_view_module_version":"1.5.0","_view_name":"HBoxView","box_style":"","children":["IPY_MODEL_b6963523ba7b4adca98c11ccd55d3622","IPY_MODEL_42544df465c944e19bcc6c8067bb0626","IPY_MODEL_b04d32997bb44296913ac8b1998b34fc"],"layout":"IPY_MODEL_cb603232c8334bf4ac1e2faa40683e50"}},"b6963523ba7b4adca98c11ccd55d3622":{"model_module":"@jupyter-widgets/controls","model_name":"HTMLModel","model_module_version":"1.5.0","state":{"_dom_classes":[],"_model_module":"@jupyter-widgets/controls","_model_module_version":"1.5.0","_model_name":"HTMLModel","_view_count":null,"_view_module":"@jupyter-widgets/controls","_view_module_version":"1.5.0","_view_name":"HTMLView","description":"","description_tooltip":null,"layout":"IPY_MODEL_cec846ccb7654b889dd13eb832c666ed","placeholder":"​","style":"IPY_MODEL_c7c82f2554184fd1ab77fd01ac22ce3e","value":"Loading checkpoint shards: 100%"}},"42544df465c944e19bcc6c8067bb0626":{"model_module":"@jupyter-widgets/controls","model_name":"FloatProgressModel","model_module_version":"1.5.0","state":{"_dom_classes":[],"_model_module":"@jupyter-widgets/controls","_model_module_version":"1.5.0","_model_name":"FloatProgressModel","_view_count":null,"_view_module":"@jupyter-widgets/controls","_view_module_version":"1.5.0","_view_name":"ProgressView","bar_style":"success","description":"","description_tooltip":null,"layout":"IPY_MODEL_0393a595d7b1413cad78cae5656273b5","max":8,"min":0,"orientation":"horizontal","style":"IPY_MODEL_2ca0d610593e4d9bb949671756adf059","value":8}},"b04d32997bb44296913ac8b1998b34fc":{"model_module":"@jupyter-widgets/controls","model_name":"HTMLModel","model_module_version":"1.5.0","state":{"_dom_classes":[],"_model_module":"@jupyter-widgets/controls","_model_module_version":"1.5.0","_model_name":"HTMLModel","_view_count":null,"_view_module":"@jupyter-widgets/controls","_view_module_version":"1.5.0","_view_name":"HTMLView","description":"","description_tooltip":null,"layout":"IPY_MODEL_2bb5de0702f1439daba4c7415a7662cf","placeholder":"​","style":"IPY_MODEL_8bde6542ded44717a248d83341fb8304","value":" 8/8 [01:33&lt;00:00, 10.36s/it]"}},"cb603232c8334bf4ac1e2faa40683e50":{"model_module":"@jupyter-widgets/base","model_name":"LayoutModel","model_module_version":"1.2.0","state":{"_model_module":"@jupyter-widgets/base","_model_module_version":"1.2.0","_model_name":"LayoutModel","_view_count":null,"_view_module":"@jupyter-widgets/base","_view_module_version":"1.2.0","_view_name":"LayoutView","align_content":null,"align_items":null,"align_self":null,"border":null,"bottom":null,"display":null,"flex":null,"flex_flow":null,"grid_area":null,"grid_auto_columns":null,"grid_auto_flow":null,"grid_auto_rows":null,"grid_column":null,"grid_gap":null,"grid_row":null,"grid_template_areas":null,"grid_template_columns":null,"grid_template_rows":null,"height":null,"justify_content":null,"justify_items":null,"left":null,"margin":null,"max_height":null,"max_width":null,"min_height":null,"min_width":null,"object_fit":null,"object_position":null,"order":null,"overflow":null,"overflow_x":null,"overflow_y":null,"padding":null,"right":null,"top":null,"visibility":null,"width":null}},"cec846ccb7654b889dd13eb832c666ed":{"model_module":"@jupyter-widgets/base","model_name":"LayoutModel","model_module_version":"1.2.0","state":{"_model_module":"@jupyter-widgets/base","_model_module_version":"1.2.0","_model_name":"LayoutModel","_view_count":null,"_view_module":"@jupyter-widgets/base","_view_module_version":"1.2.0","_view_name":"LayoutView","align_content":null,"align_items":null,"align_self":null,"border":null,"bottom":null,"display":null,"flex":null,"flex_flow":null,"grid_area":null,"grid_auto_columns":null,"grid_auto_flow":null,"grid_auto_rows":null,"grid_column":null,"grid_gap":null,"grid_row":null,"grid_template_areas":null,"grid_template_columns":null,"grid_template_rows":null,"height":null,"justify_content":null,"justify_items":null,"left":null,"margin":null,"max_height":null,"max_width":null,"min_height":null,"min_width":null,"object_fit":null,"object_position":null,"order":null,"overflow":null,"overflow_x":null,"overflow_y":null,"padding":null,"right":null,"top":null,"visibility":null,"width":null}},"c7c82f2554184fd1ab77fd01ac22ce3e":{"model_module":"@jupyter-widgets/controls","model_name":"DescriptionStyleModel","model_module_version":"1.5.0","state":{"_model_module":"@jupyter-widgets/controls","_model_module_version":"1.5.0","_model_name":"DescriptionStyleModel","_view_count":null,"_view_module":"@jupyter-widgets/base","_view_module_version":"1.2.0","_view_name":"StyleView","description_width":""}},"0393a595d7b1413cad78cae5656273b5":{"model_module":"@jupyter-widgets/base","model_name":"LayoutModel","model_module_version":"1.2.0","state":{"_model_module":"@jupyter-widgets/base","_model_module_version":"1.2.0","_model_name":"LayoutModel","_view_count":null,"_view_module":"@jupyter-widgets/base","_view_module_version":"1.2.0","_view_name":"LayoutView","align_content":null,"align_items":null,"align_self":null,"border":null,"bottom":null,"display":null,"flex":null,"flex_flow":null,"grid_area":null,"grid_auto_columns":null,"grid_auto_flow":null,"grid_auto_rows":null,"grid_column":null,"grid_gap":null,"grid_row":null,"grid_template_areas":null,"grid_template_columns":null,"grid_template_rows":null,"height":null,"justify_content":null,"justify_items":null,"left":null,"margin":null,"max_height":null,"max_width":null,"min_height":null,"min_width":null,"object_fit":null,"object_position":null,"order":null,"overflow":null,"overflow_x":null,"overflow_y":null,"padding":null,"right":null,"top":null,"visibility":null,"width":null}},"2ca0d610593e4d9bb949671756adf059":{"model_module":"@jupyter-widgets/controls","model_name":"ProgressStyleModel","model_module_version":"1.5.0","state":{"_model_module":"@jupyter-widgets/controls","_model_module_version":"1.5.0","_model_name":"ProgressStyleModel","_view_count":null,"_view_module":"@jupyter-widgets/base","_view_module_version":"1.2.0","_view_name":"StyleView","bar_color":null,"description_width":""}},"2bb5de0702f1439daba4c7415a7662cf":{"model_module":"@jupyter-widgets/base","model_name":"LayoutModel","model_module_version":"1.2.0","state":{"_model_module":"@jupyter-widgets/base","_model_module_version":"1.2.0","_model_name":"LayoutModel","_view_count":null,"_view_module":"@jupyter-widgets/base","_view_module_version":"1.2.0","_view_name":"LayoutView","align_content":null,"align_items":null,"align_self":null,"border":null,"bottom":null,"display":null,"flex":null,"flex_flow":null,"grid_area":null,"grid_auto_columns":null,"grid_auto_flow":null,"grid_auto_rows":null,"grid_column":null,"grid_gap":null,"grid_row":null,"grid_template_areas":null,"grid_template_columns":null,"grid_template_rows":null,"height":null,"justify_content":null,"justify_items":null,"left":null,"margin":null,"max_height":null,"max_width":null,"min_height":null,"min_width":null,"object_fit":null,"object_position":null,"order":null,"overflow":null,"overflow_x":null,"overflow_y":null,"padding":null,"right":null,"top":null,"visibility":null,"width":null}},"8bde6542ded44717a248d83341fb8304":{"model_module":"@jupyter-widgets/controls","model_name":"DescriptionStyleModel","model_module_version":"1.5.0","state":{"_model_module":"@jupyter-widgets/controls","_model_module_version":"1.5.0","_model_name":"DescriptionStyleModel","_view_count":null,"_view_module":"@jupyter-widgets/base","_view_module_version":"1.2.0","_view_name":"StyleView","description_width":""}}}}},"nbformat":4,"nbformat_minor":0}